Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AC010422.5 ENSG00000269590 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 13.9;RT4: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.7" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" "Nuclear membrane, Endoplasmic reticulum" "HPA065685: " 4.5 8.7 3.7 5.1 3.8 3.1 7.5 5.1 8.3 5.6 5.8 3.6 5.9 11.3 4.5 6.7 6.9 5.4 7.8 5.5 4.2 4.1 6.0 8.3 8.0 13.1 3.5 2.4 6.4 13.2 2.3 3.8 7.5 2.2 6.9 2.8 3.3 8.2 6.2 10.9 6.0 5.9 4.6 3.7 4.1 3.8 4.5 2.6 2.7 10.4 6.9 3.9 4.7 7.1 1.2 0.0 6.7 0.2 0.0 0.2 0.5 2.0 0.0 0.0 3.2 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 2.2 0.0 1.3 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.0 2.6 0.0 0.4 1.2 0.2 0.0 0.3 3.7 0.0 13.9 3.5 0.4 0.9 0.0 1.4 0.0 0.0 1.0 7.3 2.1 1.8 0.0 1.7 0.3 2.4 0.7 0.0 5.2 0.1 1.9 2.1 2.3 3.1 1.4 4.7 0.8 2.0 2.0 0.2 1.8 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.8 0.0 0.1 6.7 0.0 0.2 0.0 0.1 0.5 3.7 3.8 5.1 4.4 4.2 4.1 3.5 2.4 2.2 2.6 ADAM9 "CORD9, KIAA0021, MCMP, MDC9, Mltng" ENSG00000168615 "ADAM metallopeptidase domain 9" Q13443 8 38996869-39105144 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Cone-rod dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 11.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004000 Approved "Endoplasmic reticulum,Vesicles" "Secreted - unknown location" 640000 Vesicles "Endoplasmic reticulum" "HPA004000: AB_1844584" "prognostic unfavourable (1.14e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.32e-3)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (7.21e-6)" "unprognostic (5.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.52e-5)" "unprognostic (5.83e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (2.80e-1)" "unprognostic (5.76e-2)" "unprognostic (2.27e-1)" "unprognostic (1.23e-2)" 36.7 25.0 14.7 21.7 13.6 10.4 17.1 20.9 14.4 21.8 24.4 13.2 21.8 19.4 24.9 19.8 24.1 15.5 31.7 28.5 12.5 10.1 29.4 11.6 39.2 20.3 19.2 12.9 17.6 11.1 37.5 10.4 30.1 15.8 23.8 23.8 15.4 44.5 21.4 18.3 12.8 25.4 32.8 22.0 25.7 33.2 13.7 12.7 2.4 24.0 14.9 11.7 34.8 19.2 0.6 8.1 3.4 11.4 3.1 0.8 2.8 41.1 29.8 11.8 7.2 19.1 61.6 15.3 55.9 61.1 31.4 29.4 14.1 29.9 2.1 21.1 38.4 17.6 5.0 39.5 60.9 2.0 5.1 2.2 20.7 12.2 38.7 1.6 4.8 47.4 23.5 30.9 35.2 42.7 4.3 14.0 65.3 4.0 1.6 1.0 1.7 9.6 1.4 21.3 7.1 51.0 11.8 1.6 2.4 14.9 17.9 13.6 14.5 3.0 73.4 24.0 23.1 45.3 25.6 4.5 6.9 2.3 39.8 2.7 16.3 1.4 11.4 2.2 0.6 6.1 0.3 0.1 0.3 0.8 8.1 0.6 0.1 0.6 3.4 3.1 2.6 2.7 0.4 2.8 14.7 13.6 20.9 14.4 12.5 10.1 19.2 12.9 15.8 12.7 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 51.4" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: " "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 51.4 4.7 5.6 12.0 11.5 0.5 15.2 3.9 8.0 10.4 10.4 2.8 7.2 1.6 13.9 5.6 6.8 7.7 8.2 29.6 5.7 2.7 9.0 3.1 11.5 7.7 6.8 0.3 17.4 9.9 17.2 2.4 30.5 12.4 7.4 3.2 0.7 3.5 4.3 10.8 2.6 3.2 12.2 12.6 4.4 4.6 3.1 5.9 0.0 6.4 3.7 1.6 19.6 29.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 3.5 1.0 0.0 0.0 0.2 9.4 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.9 0.0 11.2 0.1 0.0 52.2 0.0 0.0 0.0 0.0 0.2 2.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 11.5 3.9 8.0 5.7 2.7 6.8 0.3 12.4 5.9 AGPAT1 LPAAT-alpha ENSG00000204310 "1-acylglycerol-3-phosphate O-acyltransferase 1" Q99943 6 32168212-32178096 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.4;fHDF/TERT166: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048478, HPA073355" Approved Supported "Endoplasmic reticulum,Rods & Rings" "Endoplasmic reticulum" "Rods & Rings" "HPA048478: , HPA073355: " "prognostic unfavourable (1.93e-4)" "unprognostic (9.35e-3)" "unprognostic (1.87e-3)" "prognostic unfavourable (5.21e-4)" "unprognostic (4.79e-2)" "unprognostic (7.05e-2)" "unprognostic (7.16e-3)" "unprognostic (1.55e-1)" "unprognostic (3.79e-1)" "unprognostic (4.24e-3)" "unprognostic (1.84e-3)" "unprognostic (1.77e-1)" "unprognostic (6.58e-2)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.92e-3)" "unprognostic (7.00e-2)" 11.7 32.3 21.5 8.3 33.1 7.4 12.1 18.7 32.4 26.9 22.1 19.6 19.6 32.0 25.1 53.3 13.8 26.9 22.3 19.4 22.8 21.1 26.4 20.3 24.3 10.7 20.3 23.6 33.1 18.5 1.3 16.6 18.5 22.4 18.5 24.8 17.5 17.4 19.5 25.5 9.1 46.9 17.9 18.6 11.7 27.8 27.7 17.4 12.1 33.4 9.0 14.6 19.3 12.7 6.7 13.8 13.2 9.6 8.9 10.1 5.7 0.0 0.1 13.5 0.0 35.4 23.9 12.6 0.0 0.0 0.0 0.0 27.6 0.0 0.0 11.6 33.8 3.3 29.1 9.6 0.0 0.0 22.6 0.0 0.0 29.0 0.0 0.0 27.4 13.3 12.5 0.0 12.6 8.2 17.4 17.8 29.3 7.3 0.0 6.3 0.0 4.2 0.1 0.0 0.1 8.8 0.0 0.0 0.0 13.4 4.3 15.1 16.9 0.0 5.8 0.0 5.0 0.0 0.0 10.7 10.1 4.4 17.4 0.0 0.0 2.7 5.7 13.2 9.2 9.6 8.7 6.7 5.8 10.1 10.3 5.9 5.0 7.3 11.0 8.9 6.6 13.8 7.8 5.7 21.5 33.1 18.7 32.4 22.8 21.1 20.3 23.6 22.4 17.4 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859405-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 40.5;intestine: 99.1" "Cell line enriched" "Detected in some" 41 "T-47d: 86.2" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 5.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 31000 "Endoplasmic reticulum" Vesicles "HPA053942: " "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.0 0.6 7.5 0.7 0.0 13.1 0.7 0.6 4.4 45.8 0.6 0.6 29.2 1.2 5.4 0.9 40.5 11.8 0.6 0.6 0.3 1.5 0.6 26.3 0.6 0.6 0.6 5.1 1.9 0.0 12.9 2.8 1.9 1.1 38.9 0.6 9.4 0.6 0.6 0.3 99.1 1.2 0.8 0.6 17.1 1.0 0.6 0.6 1.4 1.9 3.9 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 0.1 0.0 0.1 0.0 86.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 0.6 0.6 0.3 0.6 0.6 1.9 0.6 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Group enriched" "Detected in many" 10 "ASC diff: 186.6;Hep G2: 316.4" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: " "unprognostic (1.54e-2)" "prognostic favourable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavourable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favourable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.6 0.1 25.8 186.6 22.5 0.0 0.8 5.7 0.3 0.2 0.5 0.0 0.0 0.3 5.8 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.2 316.4 1.8 0.1 0.0 11.4 1.6 2.7 1.6 0.6 5.5 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Cell line enhanced" "Detected in many" "Daudi: 16.8;HDLM-2: 11.2;HEL: 12.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.0 3.1 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.2 16.8 2.0 0.2 7.6 1.6 1.7 0.6 11.2 0.2 12.2 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 3.0 2.8 0.2 0.6 1.4 0.9 0.2 2.8 5.9 0.6 5.4 0.0 0.0 0.3 0.3 0.5 5.2 1.3 5.0 1.3 0.0 1.2 1.9 0.4 0.6 1.4 2.8 7.5 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 ALB ENSG00000163631 Albumin P02768 4 73397114-73421412 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 3075.8" "Cell line enriched" "Detected in some" 39 "Hep G2: 308.4" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavourable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 4.9 3075.8 0.1 0.1 0.1 0.1 0.1 38.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.1 308.4 0.0 7.9 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 6.8 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 0.0 2.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.1 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033960-5087379 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favourable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.0 22.2 8.7 10.8 12.8 6.6 12.8 9.3 18.8 13.7 16.4 14.9 10.1 14.7 12.1 17.0 11.7 12.4 14.3 8.1 8.8 10.4 18.9 31.6 9.9 12.7 10.5 6.5 10.1 27.9 21.5 13.6 10.7 14.6 10.8 17.2 15.5 20.6 12.0 7.3 9.1 12.8 12.1 9.4 16.2 16.5 19.4 11.4 16.0 15.0 8.7 14.5 12.1 8.7 20.7 24.3 7.8 23.3 20.9 26.5 31.7 6.4 17.6 4.4 8.3 17.0 10.1 8.2 14.5 20.4 19.0 19.0 14.5 23.9 13.7 12.5 18.5 17.4 12.1 14.3 12.9 11.2 13.8 7.7 14.6 29.9 13.9 13.4 13.5 12.3 10.9 14.9 9.4 11.3 9.6 18.0 14.1 17.5 8.6 16.5 16.8 10.1 16.0 6.1 38.2 11.8 7.0 7.5 7.6 15.5 24.3 8.3 15.8 11.0 10.8 8.8 8.2 45.0 12.1 13.1 15.8 9.3 7.3 14.4 12.5 3.3 23.3 7.8 26.5 21.6 23.1 19.8 22.9 25.4 24.3 20.7 21.0 23.7 1.5 20.9 21.2 21.2 21.6 31.7 8.7 12.8 9.3 18.8 8.8 10.4 10.5 6.5 14.6 11.4 ALG1L2 ENSG00000251287 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 3.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.5;HDLM-2: 1.9;HEL: 1.7;Karpas-707: 1.3;REH: 2.8" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 4.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 4.0" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: " "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favourable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.1 0.7 4.0 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.5 0.1 0.0 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.6 0.3 0.3 0.4 0.1 0.0 0.0 0.0 4.0 0.9 0.1 ALKBH1 "ABH, alkB, ALKBH, hABH" ENSG00000100601 "AlkB homolog 1, histone H2A dioxygenase" Q13686 14 77672404-77708020 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, RNA repair, Translation regulation" "Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044087, HPA060061" Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Intracellular and membrane" Nucleoplasm "Endoplasmic reticulum" "HPA044087: , HPA060061: " "unprognostic (1.92e-2)" "unprognostic (8.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-3)" "unprognostic (3.41e-2)" "unprognostic (5.03e-2)" "unprognostic (3.74e-3)" "unprognostic (7.45e-3)" "unprognostic (2.68e-2)" "unprognostic (3.95e-2)" "unprognostic (5.05e-3)" "unprognostic (2.16e-2)" "prognostic favourable (1.80e-4)" "unprognostic (1.65e-3)" "unprognostic (1.46e-1)" "unprognostic (2.63e-1)" "unprognostic (2.44e-2)" 8.2 8.5 6.2 6.7 8.6 2.7 9.7 9.6 8.8 9.7 9.1 8.2 4.5 6.5 7.0 5.9 7.1 8.0 5.8 11.1 5.4 5.7 7.9 9.4 5.9 8.3 6.5 3.7 8.3 7.9 8.4 11.2 10.2 6.4 9.3 9.1 9.9 7.2 8.7 16.5 8.2 6.7 7.8 5.5 8.3 7.8 9.9 6.6 12.7 8.8 6.5 10.3 8.5 9.4 5.4 4.9 11.4 5.7 5.2 5.3 3.2 5.2 7.8 6.4 4.3 6.9 7.5 8.0 5.5 7.2 12.2 13.7 7.9 3.2 8.1 3.1 5.0 4.8 13.9 5.9 14.4 5.5 5.4 4.3 4.6 6.6 9.7 4.5 2.8 6.4 9.9 7.1 11.3 9.9 6.6 4.7 6.5 8.3 6.0 5.9 7.0 10.1 6.1 6.5 5.4 7.0 4.7 8.2 6.1 4.5 4.7 5.9 11.6 4.7 4.5 5.1 5.2 5.6 4.4 5.9 9.3 7.9 3.4 6.5 5.0 11.4 5.0 2.2 5.0 5.7 4.3 5.4 4.7 5.0 4.9 4.9 5.0 3.9 1.4 5.2 3.8 2.6 5.3 3.2 6.2 8.6 9.6 8.8 5.4 5.7 6.5 3.7 6.4 6.6 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425538 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: , HPA077835: " "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 13.9 25.9 21.3 10.6 23.8 14.1 28.7 12.6 25.0 17.2 21.0 24.5 18.5 21.6 16.6 25.2 20.8 15.3 13.7 17.6 20.6 20.2 35.2 50.0 13.3 19.3 22.3 14.3 20.5 14.0 33.3 13.0 41.6 18.9 14.9 11.8 23.8 12.6 18.6 71.6 11.9 18.8 16.0 25.0 14.3 12.2 36.8 17.5 14.6 18.6 10.1 19.3 15.5 16.9 18.3 10.6 21.4 13.1 11.7 9.7 4.0 17.4 24.4 10.7 19.6 33.4 18.8 9.4 18.9 23.4 25.7 20.2 21.6 16.6 45.6 21.9 25.5 16.4 16.3 14.7 24.6 10.2 16.8 13.8 10.1 23.2 29.3 10.7 16.0 21.8 21.3 20.5 24.6 14.9 14.3 6.3 18.6 11.1 16.0 11.4 5.0 16.8 18.1 21.5 17.1 15.9 18.3 10.7 8.2 44.4 15.6 14.3 46.9 11.2 19.3 24.3 13.3 12.3 12.7 13.6 11.9 24.2 17.6 7.8 11.1 21.4 8.5 10.9 6.9 9.9 9.7 18.3 8.7 7.1 7.8 15.6 9.1 9.5 10.5 11.7 13.1 10.6 9.0 4.0 21.3 23.8 12.6 25.0 20.6 20.2 22.3 14.3 18.9 17.5 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavourable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavourable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 20.8 19.5 20.5 12.6 11.9 18.8 25.7 25.5 19.1 25.6 19.7 22.2 14.3 16.4 13.4 22.4 25.2 17.8 23.2 24.6 7.0 22.1 20.8 32.7 10.4 13.3 22.4 14.7 17.4 23.8 24.3 18.1 18.2 18.7 6.5 26.1 15.0 20.8 37.0 17.3 18.8 24.0 13.4 6.9 18.4 27.3 25.1 15.5 32.9 13.9 11.2 24.4 16.3 26.0 30.9 22.3 16.4 28.4 12.1 11.9 20.1 23.9 14.9 17.3 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 ARHGAP5 "GFI2, p190-B, p190BRhoGAP, RhoGAP5" ENSG00000100852 "Rho GTPase activating protein 5" Q13017 14 32076114-32159728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046993, HPA056507" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA046993: , HPA056507: " "unprognostic (1.79e-1)" "unprognostic (2.03e-1)" "unprognostic (2.66e-3)" "unprognostic (6.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (1.55e-2)" "unprognostic (6.23e-2)" "unprognostic (2.88e-1)" "unprognostic (2.18e-1)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "prognostic favourable (3.97e-8)" "unprognostic (9.79e-2)" "unprognostic (2.21e-1)" "unprognostic (2.13e-1)" "unprognostic (1.00e-2)" 11.3 13.1 29.8 8.4 26.1 4.0 13.0 39.1 29.2 14.2 14.6 11.5 7.9 16.0 13.2 11.9 31.5 11.1 15.3 28.0 29.5 19.6 20.8 14.5 12.8 5.9 26.8 23.4 23.3 13.5 21.8 27.6 16.9 24.2 14.7 12.3 9.2 26.0 14.5 11.5 14.0 17.3 13.4 26.6 18.7 13.3 20.4 30.6 8.8 32.5 7.7 8.0 15.6 25.8 7.3 9.0 1.5 1.8 6.8 7.4 2.3 18.6 15.2 15.2 22.2 20.0 14.1 8.7 11.6 14.4 7.1 10.7 19.3 18.3 5.5 10.4 14.7 19.9 14.5 12.5 13.9 5.5 8.4 8.3 9.4 28.2 13.6 5.0 5.0 15.6 25.5 6.6 25.0 8.7 7.3 16.5 11.5 9.8 10.9 0.2 7.5 18.3 11.9 18.7 1.0 15.6 49.9 23.6 9.2 31.3 16.8 23.7 17.4 0.3 13.9 13.2 19.9 10.9 8.5 6.3 12.3 0.8 6.6 5.4 35.9 1.5 1.8 0.0 4.0 0.8 4.8 7.3 7.0 3.7 6.1 7.1 7.4 4.3 0.6 6.8 1.3 9.0 5.7 2.3 29.8 26.1 39.1 29.2 29.5 19.6 26.8 23.4 24.2 30.6 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell line enriched" "Detected in some" 8 "Hep G2: 105.4" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 BGN "DSPG1, SLRR1A" ENSG00000182492 Biglycan P21810 X 153494939-153509554 "Disease related genes, Predicted secreted proteins" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 45.5;BJ hTERT+: 58.9;fHDF/TERT166: 82.2;HSkMC: 43.2;hTEC/SVTERT24-B: 34.9;HUVEC TERT2: 82.4;U-138 MG: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003157, CAB003678" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" 2500000 "Golgi apparatus" "Endoplasmic reticulum" "CAB003678: AB_425325, HPA003157: AB_1078282" "unprognostic (1.74e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-3)" "unprognostic (3.60e-1)" "unprognostic (5.42e-2)" "unprognostic (3.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.22e-2)" "unprognostic (1.76e-3)" "unprognostic (1.30e-2)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "prognostic unfavourable (6.00e-8)" "unprognostic (7.05e-3)" "unprognostic (2.40e-2)" "unprognostic (5.66e-2)" "unprognostic (2.57e-3)" 41.1 39.7 8.1 23.2 14.6 0.4 20.2 5.6 14.3 76.7 12.0 18.7 16.7 6.0 63.4 31.7 21.1 23.6 86.7 133.0 8.9 5.2 67.6 78.1 77.6 29.4 8.9 16.3 39.6 16.8 5.1 26.7 131.1 15.0 33.6 7.0 48.3 20.4 38.2 17.0 31.0 8.6 56.9 5.9 101.3 10.0 28.0 15.8 3.9 45.3 29.9 14.6 34.5 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.7 10.8 0.1 45.5 58.9 8.4 2.8 5.7 0.0 0.0 8.4 82.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.0 43.2 0.3 34.9 1.6 82.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 17.4 37.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 14.6 5.6 14.3 8.9 5.2 8.9 16.3 15.0 15.8 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;Karpas-707: 8.4;U-266/70: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA057157: " "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.2 0.4 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.7 1.6 0.1 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.4 5.8 2.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16756881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: " "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavourable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 44.5 47.1 34.7 37.8 49.0 34.7 40.5 59.7 43.0 40.3 42.1 32.3 29.7 27.3 54.1 35.3 51.6 36.3 34.0 55.1 32.4 33.3 42.6 56.4 41.6 43.0 36.5 38.9 54.2 39.6 35.8 53.7 58.9 35.7 42.0 23.6 30.6 40.1 36.3 69.5 36.4 28.4 43.0 38.9 41.1 35.1 27.5 33.9 50.6 47.6 32.6 36.5 52.0 39.2 97.7 91.8 87.4 74.8 67.4 91.1 123.2 65.4 52.8 63.1 31.1 35.2 32.1 44.4 65.2 33.9 43.4 39.8 49.9 62.2 56.6 52.4 39.5 38.3 42.4 30.7 47.1 74.3 45.4 50.0 45.6 45.0 43.6 71.5 45.0 31.7 43.1 25.8 57.0 30.3 62.5 39.5 37.3 38.3 76.6 34.8 46.7 30.1 62.5 63.7 29.8 33.7 37.6 43.4 44.4 57.0 43.3 77.5 38.5 49.7 56.5 54.6 44.6 65.2 61.5 26.5 97.8 78.7 47.5 41.7 49.8 78.3 65.8 87.4 72.2 72.9 83.0 97.7 80.2 75.8 71.4 89.3 91.1 78.9 31.3 67.4 74.8 91.8 81.5 123.2 34.7 49.0 59.7 43.0 32.4 33.3 36.5 38.9 35.7 33.9 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line alpha subunit 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved "Endoplasmic reticulum,Cytosol" 19000000 "Endoplasmic reticulum" Cytosol "HPA007470: AB_1845985, HPA007643: " "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavourable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favourable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 32.4 17.7 23.6 15.8 22.6 33.6 18.5 17.6 30.2 17.7 26.3 10.7 13.5 16.9 20.6 16.4 25.9 14.9 17.6 36.4 26.7 20.6 40.9 29.2 23.2 16.6 22.1 15.9 17.3 13.8 12.9 16.4 26.1 27.1 21.8 20.6 11.8 14.4 18.3 47.1 11.6 30.6 30.3 19.6 26.0 17.8 12.4 13.7 17.7 24.5 21.0 14.0 31.5 15.0 6.6 14.8 32.0 22.8 7.1 7.8 17.7 12.9 8.8 8.5 11.1 16.3 17.3 4.7 12.8 18.1 12.9 14.8 6.4 16.6 8.8 21.0 18.1 8.1 8.8 10.5 20.0 9.6 7.0 13.2 8.7 10.7 10.1 8.8 17.9 13.9 11.8 10.5 9.9 27.1 8.8 15.3 25.3 6.3 11.4 14.8 12.6 7.6 8.1 11.5 17.4 30.0 11.1 9.1 10.4 11.9 44.9 12.2 6.3 10.2 10.0 20.7 6.6 16.3 12.0 12.1 8.8 16.8 12.3 12.5 14.7 19.9 16.4 19.2 5.5 20.1 6.1 6.6 6.5 5.7 14.8 6.0 6.4 6.5 32.0 7.1 22.8 8.2 7.8 17.7 23.6 22.6 17.6 30.2 26.7 20.6 22.1 15.9 27.1 13.7 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 201.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882" Approved Enhanced "Endoplasmic reticulum,Cytosol" 18000000 "Endoplasmic reticulum, Cytosol" "CAB009491: AB_2259755, HPA036881: , HPA036882: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavourable (4.98e-4)" 38.3 20.7 10.4 25.0 16.3 22.1 32.0 8.7 21.7 38.0 44.6 10.5 18.6 25.6 24.8 25.9 87.4 19.5 25.5 98.5 11.9 10.6 27.2 38.2 29.5 21.1 14.3 12.5 26.9 14.8 22.3 25.3 52.6 24.8 30.0 34.5 12.7 38.7 23.2 201.9 40.7 56.3 36.2 18.7 21.7 22.2 21.2 15.6 10.1 25.6 51.2 34.1 42.2 57.0 24.5 32.7 12.4 48.0 18.3 26.6 27.2 47.9 39.6 6.7 17.5 40.6 75.7 23.7 34.2 48.4 27.4 35.7 9.7 29.3 6.9 32.4 46.3 81.7 12.7 46.5 33.2 44.6 12.0 8.9 41.9 11.6 31.2 5.8 15.5 34.2 43.1 39.3 64.1 30.6 7.5 22.4 33.3 15.1 2.8 0.2 5.2 14.7 2.7 22.7 11.8 54.4 20.3 28.4 6.8 34.9 19.2 22.3 11.7 6.3 40.6 37.4 15.9 24.9 34.5 7.5 20.0 3.2 42.4 3.1 10.3 2.5 48.0 7.0 26.6 29.0 25.2 24.5 23.9 26.5 32.7 22.7 12.2 16.3 12.4 18.3 32.2 9.0 24.2 27.2 10.4 16.3 8.7 21.7 11.9 10.6 14.3 12.5 24.8 15.6 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.7;Karpas-707: 72.4;U-266/84: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 52.9;neutrophil: 59.9" "Group enriched" "Detected in all" 7 "granulocytes: 59.9;monocytes: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: , HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavourable (5.07e-4)" "prognostic unfavourable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 22.4 20.3 21.1 11.2 34.8 29.5 20.2 27.6 27.7 32.1 16.0 9.9 28.2 11.9 16.0 19.4 12.7 11.7 26.6 29.7 21.2 26.1 27.5 56.2 23.3 19.8 21.8 18.5 17.4 41.6 37.7 56.3 13.4 21.7 21.0 16.5 13.5 33.1 27.4 44.2 7.8 16.9 16.7 23.2 19.5 22.2 13.8 19.7 5.2 41.9 12.9 11.3 20.0 16.7 3.7 5.5 59.9 15.4 4.9 5.6 5.6 2.8 10.4 2.3 5.2 38.3 13.0 3.3 6.2 11.9 3.7 5.7 3.0 5.0 4.3 21.5 20.6 3.9 2.0 5.3 3.1 11.4 3.1 5.8 13.2 2.7 49.7 8.0 18.1 10.9 12.8 7.8 7.6 13.6 9.7 72.4 11.7 3.9 0.0 4.0 1.4 2.7 1.3 3.7 17.2 7.8 2.1 3.0 4.6 7.4 4.1 31.6 6.6 17.7 13.7 11.0 2.4 8.3 4.2 14.0 51.1 2.7 20.7 16.1 8.7 34.6 11.5 52.9 5.6 10.1 4.8 3.7 3.6 4.3 5.5 2.8 3.1 4.3 59.9 4.9 15.4 0.9 4.4 5.6 21.1 34.8 27.6 27.7 21.2 26.1 21.8 18.5 21.7 19.7 CDS2 ENSG00000101290 "CDP-diacylglycerol synthase 2" O95674 20 5126786-5197887 "Enzymes, Plasma proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/84: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019698 Approved Approved "Endoplasmic reticulum,Cytosol" 200000 "Endoplasmic reticulum" Cytosol "HPA019698: AB_1846464" "unprognostic (4.59e-2)" "unprognostic (1.98e-1)" "unprognostic (2.39e-1)" "unprognostic (3.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.48e-1)" "unprognostic (3.35e-3)" "unprognostic (1.65e-1)" "prognostic favourable (3.53e-9)" "unprognostic (8.89e-2)" "unprognostic (3.53e-1)" "unprognostic (1.38e-1)" "unprognostic (2.44e-1)" 14.8 16.1 22.2 9.9 25.5 12.1 12.1 36.0 34.5 12.7 11.8 21.4 6.7 5.9 12.9 9.8 10.5 12.5 10.0 26.6 22.0 34.0 16.9 14.2 14.5 10.9 26.7 24.0 10.9 7.2 20.6 15.6 11.1 28.3 15.9 12.3 19.8 8.0 19.7 9.4 6.2 9.9 20.2 16.2 9.8 10.6 13.0 12.5 8.1 14.2 4.6 13.6 11.6 8.2 7.6 7.9 28.3 9.7 6.5 11.1 11.7 9.4 10.6 10.6 5.5 6.3 5.8 4.9 5.2 10.7 8.6 12.5 6.5 9.3 7.2 2.6 9.7 13.6 8.6 10.9 9.2 7.6 3.0 8.3 3.0 10.0 5.9 5.4 3.1 5.0 6.1 11.3 4.4 11.5 4.0 9.3 8.0 1.6 10.6 2.0 5.1 3.2 9.2 8.6 3.3 5.5 9.2 4.4 6.2 5.8 9.9 13.4 6.1 2.5 8.4 6.2 4.9 5.5 5.2 8.1 59.6 6.0 2.8 4.2 3.7 24.1 9.7 11.5 10.0 8.0 10.6 7.6 10.2 11.1 7.9 7.4 8.0 7.8 28.3 6.5 7.3 6.3 11.1 11.7 22.2 25.5 36.0 31.6 22.0 34.0 26.7 24.0 28.3 12.5 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027262 Approved Supported "Nuclear membrane,Endoplasmic reticulum" 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717" "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.7 28.2 23.8 51.0 71.1 43.7 17.8 26.4 38.8 50.3 34.6 29.5 45.7 22.7 44.1 41.4 29.4 33.0 28.1 41.4 30.8 26.9 31.3 19.8 35.8 51.5 35.5 38.8 39.7 36.3 44.4 55.4 31.3 33.5 52.0 62.8 38.8 23.2 20.5 36.5 50.5 26.5 16.2 36.2 54.5 21.9 22.0 34.3 29.1 51.7 30.1 61.6 53.9 24.3 36.5 16.4 32.9 46.4 33.7 37.8 142.5 41.0 15.2 36.9 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961237-66975148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8;liver: 26.7" "Cell line enhanced" "Detected in many" "AN3-CA: 8.9;Daudi: 9.8;U-937: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" 1200000 "Nuclear membrane, Endoplasmic reticulum" "HPA041008: , HPA041307: " "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favourable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.5 0.1 0.8 13.3 1.3 0.2 1.0 1.6 1.3 0.6 40.7 0.7 1.4 16.8 0.4 0.7 2.2 1.5 3.0 0.7 1.5 1.0 6.8 26.7 0.9 0.2 0.8 1.1 0.5 7.8 0.0 1.1 0.4 2.2 0.4 17.9 1.1 5.9 0.6 12.9 0.5 41.8 0.5 0.9 0.2 4.6 0.9 0.6 0.5 0.4 2.4 0.5 0.4 0.3 0.7 0.6 2.7 0.6 0.3 0.9 0.2 0.5 3.5 0.4 8.9 0.3 0.2 1.4 0.3 0.2 0.4 0.6 0.5 4.4 9.8 3.0 0.0 0.7 1.4 0.7 0.2 1.6 6.5 4.9 1.4 2.9 0.1 1.1 0.7 0.4 1.1 1.0 0.2 0.0 3.1 2.1 0.4 1.4 1.6 1.7 1.5 0.6 1.5 0.8 1.5 0.1 0.5 0.5 1.0 0.3 6.7 0.2 5.9 7.5 0.4 0.5 2.8 0.8 0.2 1.1 4.0 1.4 0.3 8.3 0.3 0.6 0.6 2.7 0.3 0.3 0.5 0.5 0.6 0.4 0.6 0.7 0.9 0.6 2.0 0.3 0.4 0.3 0.9 0.2 0.8 1.3 1.6 1.3 1.5 1.0 0.8 1.1 2.2 0.6 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624119-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7" "Group enriched" "Detected in some" 16 "SCLC-21H: 20.2;SH-SY5Y: 26.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6" "Not detected" "Not detected" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.2 6.6 2.7 3.9 0.8 0.7 0.2 0.5 0.4 0.6 2.3 0.2 0.0 0.2 0.8 0.7 1.4 0.1 0.1 0.8 1.0 0.3 0.5 0.1 0.1 2.9 0.2 0.0 0.3 0.2 0.0 1.6 0.0 1.3 0.2 1.1 10.6 2.2 2.4 0.6 0.3 1.0 0.9 1.0 1.0 0.8 10.7 0.1 18.5 0.4 0.3 1.1 0.5 0.5 1.5 0.4 1.4 0.8 1.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.2 26.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.3 0.5 0.2 0.6 0.9 0.5 0.6 0.2 1.5 0.8 0.8 1.4 1.0 0.4 0.4 0.3 0.0 2.7 0.8 0.5 0.4 1.0 0.3 0.2 0.0 1.3 0.1 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.0;HUVEC TERT2: 92.2;TIME: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: " "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favourable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 92.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell line enhanced" "Detected in many" "HaCaT: 10.7;hTERT-HME1: 6.1;RPTEC TERT1: 9.8" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA048543: " "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favourable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favourable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.2 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 10.7 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.0 0.7 0.6 0.3 3.5 0.2 0.4 3.6 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.6 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell line enhanced" "Detected in many" "Hep G2: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: " "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.5 3.9 7.4 5.0 0.0 0.0 4.4 2.8 0.2 0.0 0.0 3.0 1.5 3.1 0.7 0.0 1.1 0.0 0.4 0.0 2.5 6.8 5.2 2.1 24.3 0.0 1.7 1.0 0.2 0.0 0.0 0.0 0.3 7.2 9.0 0.0 0.8 3.0 5.5 0.5 1.7 6.2 3.5 10.8 0.8 0.7 6.5 4.5 2.9 1.8 2.2 2.4 0.7 0.6 3.0 4.3 2.1 1.4 5.1 8.9 6.4 2.4 3.3 2.5 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Cell line enhanced" "Detected in some" "HDLM-2: 23.4;RT4: 9.9;SCLC-21H: 6.7;U-2 OS: 5.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavourable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavourable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.9 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164565-227314792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.9" "Cell line enhanced" "Detected in some" "HeLa: 16.1;Karpas-707: 9.5;RPTEC TERT1: 10.7;U-266/70: 8.8" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 3.8;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 7 "B-cells: 3.8" "Not detected" "Not detected" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favourable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.7 9.5 0.9 5.4 2.9 0.3 0.9 1.4 2.9 0.7 0.7 1.7 12.0 0.7 1.5 15.3 1.1 1.5 5.3 6.7 1.6 1.2 27.9 0.7 15.0 3.6 2.4 0.0 3.6 4.4 0.2 16.7 0.2 7.5 4.9 1.0 20.9 1.1 11.2 17.8 0.6 5.0 2.9 3.1 6.1 1.5 1.5 3.4 0.0 16.2 9.4 5.8 1.8 1.2 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 2.9 10.7 2.1 0.5 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 8.8 3.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.9 1.4 2.9 1.6 1.2 2.4 0.0 7.5 3.4 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell line enhanced" "Detected in many" "MCF7: 118.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Supported "Endoplasmic reticulum,Vesicles" 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favourable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favourable (5.67e-4)" "prognostic unfavourable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.0 19.6 2.2 19.4 22.1 19.7 0.8 21.6 27.3 18.5 21.3 16.6 22.2 7.7 9.6 30.9 26.1 3.7 23.2 4.9 16.6 24.7 13.7 10.5 38.7 41.3 22.8 5.5 25.0 28.7 16.1 16.0 17.4 55.4 16.4 15.0 118.0 8.9 41.0 4.8 6.6 13.5 19.4 10.6 19.6 60.5 9.5 8.3 7.2 61.3 17.8 13.2 64.3 20.8 33.2 12.7 10.9 16.2 6.0 2.5 6.3 35.8 30.9 22.8 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: " "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.2 11.8 0.2 20.2 20.1 8.9 20.0 32.5 14.1 14.2 8.5 3.6 0.8 5.4 21.7 2.1 6.9 14.7 27.6 5.8 3.4 25.3 8.5 20.2 13.4 7.6 36.3 8.3 9.4 17.7 20.8 18.5 13.0 11.8 16.4 7.2 2.4 9.4 4.2 4.4 5.3 6.4 6.7 11.0 4.1 3.0 7.1 6.5 16.9 8.9 2.4 5.7 19.7 18.9 2.9 22.7 7.3 14.0 4.8 5.3 22.7 21.5 41.9 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell line enhanced" "Detected in some" "HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" "Nuclear membrane, Endoplasmic reticulum" "HPA067201: " "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavourable (7.43e-4)" "prognostic unfavourable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavourable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 33.5 0.0 1.7 0.0 0.0 0.0 81.5 0.1 0.0 1.2 1.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 5.1 0.0 0.0 11.4 0.0 7.9 0.0 0.0 0.2 0.0 0.0 0.0 1.0 19.7 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 201.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 37 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 201.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: " "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favourable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 29.5 47.3 28.5 18.6 45.7 17.8 20.5 33.4 38.2 22.1 23.9 29.8 23.7 35.3 21.5 17.8 21.1 21.0 24.3 17.7 27.0 21.8 28.5 54.0 27.0 17.5 47.9 22.9 23.9 43.6 37.5 17.7 31.3 30.9 27.3 16.6 20.6 48.5 29.3 29.5 22.2 31.9 17.1 36.8 20.2 31.5 14.7 39.3 12.6 34.0 14.2 16.2 20.8 29.4 15.1 32.0 24.4 20.2 12.3 21.0 12.9 29.5 37.3 9.2 17.2 21.0 8.0 13.3 18.9 9.1 11.7 12.8 29.3 21.6 17.7 15.4 10.4 33.2 9.5 28.2 4.3 12.0 17.7 15.0 12.4 50.8 28.8 16.9 16.3 12.5 27.7 22.3 16.0 10.6 20.7 21.3 7.4 16.2 11.5 31.5 11.4 17.2 15.3 8.2 26.9 18.9 27.8 20.5 12.6 19.4 54.9 17.5 23.3 10.4 16.0 18.8 8.4 13.2 28.7 16.0 18.0 7.5 5.2 14.3 10.9 11.7 20.2 24.4 19.6 13.3 19.5 15.1 20.9 21.0 20.5 15.1 18.7 18.2 5.4 12.3 12.1 32.0 18.6 12.9 28.5 45.7 33.4 38.2 27.0 21.8 47.9 22.9 30.9 39.3 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.1 1.9 3.6 3.2 1.3 2.3 2.7 2.7 2.6 1.8 9.7 2.6 1.5 10.6 1.7 3.3 1.6 3.7 0.5 2.8 4.0 2.8 3.3 15.8 2.3 0.7 2.9 1.8 2.9 1.6 1.9 2.0 2.2 3.5 1.7 3.2 4.8 3.1 0.9 17.6 6.2 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.0 0.4 0.6 1.4 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favourable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavourable (5.67e-4)" 8.0 40.1 12.1 5.6 14.5 19.0 16.8 5.3 22.8 5.5 9.3 27.9 8.8 20.8 4.0 27.3 14.6 5.2 5.8 10.7 13.7 13.2 7.1 64.8 12.0 2.7 20.6 12.3 21.5 7.3 14.0 7.0 3.7 23.4 10.0 6.6 16.6 10.0 3.9 5.4 22.9 15.8 4.5 20.5 5.9 8.5 17.7 15.5 2.8 5.4 12.1 7.7 4.3 7.4 6.3 6.2 3.5 1.9 4.6 12.1 5.7 21.6 19.6 19.2 21.2 9.0 14.0 6.0 8.9 23.8 7.6 20.8 73.0 71.1 15.1 14.3 8.5 41.6 22.8 48.3 8.1 5.7 17.1 5.7 16.6 31.2 23.1 10.8 2.8 16.2 21.4 28.6 19.7 11.2 27.0 32.3 7.6 58.1 8.9 12.2 27.5 11.7 8.1 27.0 65.0 28.6 32.7 26.1 9.7 8.5 28.2 20.3 27.3 5.9 10.6 2.1 11.6 0.6 10.7 10.7 12.9 16.1 6.1 19.2 8.6 3.5 1.9 1.7 9.7 1.2 11.8 6.3 8.2 9.0 2.5 5.4 10.5 12.1 1.0 4.6 1.2 6.2 5.1 5.7 12.1 14.5 5.3 22.8 13.7 13.2 20.6 12.3 23.4 15.5 DNAJB12 "DJ10, FLJ20027" ENSG00000148719 "DnaJ heat shock protein family (Hsp40) member B12" Q9NXW2 10 72332830-72355230 "Predicted membrane proteins, Transporters" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010642, HPA072702" Approved Supported "Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear membrane" "HPA010642: AB_1078692, HPA072702: " "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (4.79e-4)" "unprognostic (6.01e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (8.17e-4)" "unprognostic (5.73e-2)" "unprognostic (5.60e-2)" "unprognostic (8.85e-3)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (4.73e-1)" "unprognostic (1.16e-2)" "unprognostic (1.87e-1)" 24.9 31.7 18.6 20.1 20.6 27.2 32.6 24.0 28.3 24.1 21.8 29.9 26.4 25.0 26.8 31.0 23.8 21.1 28.7 25.3 18.0 17.3 25.6 34.3 26.8 27.5 19.9 19.4 25.4 33.1 38.4 26.2 36.0 20.2 24.5 17.5 27.5 32.4 44.8 40.3 28.6 27.4 22.8 22.3 26.9 24.3 29.2 18.2 20.8 25.5 25.8 23.5 21.1 21.2 7.6 15.5 23.3 19.8 8.3 8.7 9.9 15.5 16.1 10.2 17.0 13.4 13.6 12.9 15.6 27.1 21.5 20.1 18.9 27.1 11.5 12.6 18.8 26.1 9.4 14.0 11.4 12.5 12.8 6.1 9.6 12.2 29.5 12.4 23.5 17.5 29.1 19.0 24.1 14.9 9.6 17.3 17.8 15.0 10.6 10.6 4.7 4.7 9.8 7.7 7.9 15.8 9.1 7.0 10.1 8.5 31.6 15.2 12.1 14.3 16.7 10.8 14.8 12.0 19.5 14.7 10.9 6.7 17.8 13.7 7.3 9.1 18.1 11.0 8.7 19.8 7.8 7.6 8.6 6.5 15.5 7.3 7.2 7.1 23.3 8.3 16.8 10.5 8.7 9.9 18.6 20.6 24.0 28.3 18.0 17.3 19.9 19.4 20.2 18.2 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569568-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 33.6;Karpas-707: 30.6;U-266/70: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 13.7 28.9 11.6 9.7 14.1 16.7 14.6 8.6 15.4 18.2 11.1 10.0 33.7 11.1 12.6 31.4 8.7 12.8 10.8 24.2 11.6 18.7 29.2 54.3 16.1 13.3 14.0 11.4 14.6 47.9 6.9 31.0 51.2 15.7 14.2 9.6 10.1 32.2 29.5 29.4 7.6 10.8 10.7 14.7 10.8 11.9 18.5 10.6 5.4 37.4 7.2 14.2 18.1 13.5 10.0 30.1 25.8 7.7 9.9 24.0 11.4 2.5 2.9 4.0 4.5 11.1 8.0 8.8 9.3 11.3 5.1 6.2 2.9 4.9 3.3 10.4 2.9 3.0 4.4 2.2 5.3 3.6 2.4 1.7 2.0 8.9 33.6 2.6 3.5 5.6 17.8 3.0 16.7 5.3 2.5 30.6 8.0 3.7 2.4 3.1 4.0 1.6 1.6 4.0 17.4 4.2 1.6 2.7 5.8 3.4 15.6 17.0 2.9 3.7 6.1 5.4 2.5 6.7 3.2 54.0 17.2 3.8 4.8 3.4 4.9 25.8 7.7 3.5 14.1 5.8 24.0 10.0 15.4 14.1 5.7 8.1 8.9 10.2 2.1 9.9 6.2 30.1 8.9 11.4 11.6 14.1 8.6 15.4 11.6 18.7 14.0 11.4 15.7 10.6 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9;U-698: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 3.8 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 10.7 2.2 35.3 6.6 2.8 20.5 3.9 1.5 3.6 29.9 5.4 23.5 6.2 10.0 0.4 4.0 5.6 8.1 11.5 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 EIF2S2 "EIF2, EIF2beta, PPP1R67" ENSG00000125977 "Eukaryotic translation initiation factor 2 subunit beta" P20042 20 34088298-34112332 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034415, HPA041262, HPA041332" Approved Supported "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "CAB034415: AB_2095998, HPA041262: , HPA041332: " "unprognostic (5.76e-3)" "unprognostic (7.12e-2)" "unprognostic (2.66e-2)" "prognostic unfavourable (8.74e-4)" "unprognostic (1.02e-1)" "unprognostic (1.47e-3)" "prognostic unfavourable (3.23e-5)" "unprognostic (9.36e-3)" "unprognostic (2.39e-1)" "unprognostic (6.55e-3)" "unprognostic (3.04e-3)" "unprognostic (1.25e-2)" "prognostic unfavourable (9.64e-10)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-2)" 25.9 30.1 32.8 23.3 40.7 21.4 38.1 20.2 37.7 21.1 24.3 10.9 27.1 21.2 21.2 22.4 36.3 17.0 18.3 36.3 30.1 20.4 22.0 40.1 27.2 37.7 40.0 26.2 19.9 45.4 18.7 22.4 29.9 35.8 20.4 24.7 7.4 26.3 25.5 101.8 21.2 20.4 37.0 50.2 23.0 28.1 19.6 35.6 18.2 24.1 32.7 30.1 25.0 30.7 38.8 48.5 28.1 39.3 32.4 42.4 27.3 38.9 26.2 19.9 24.0 19.5 29.7 38.0 35.7 34.3 35.6 36.0 92.0 27.4 35.0 26.3 32.2 36.9 32.3 58.7 43.3 11.2 17.6 69.3 21.6 47.0 50.4 44.3 22.6 30.3 50.1 35.2 52.7 37.2 40.6 33.5 29.2 25.0 41.0 37.0 19.3 47.9 23.7 33.9 32.3 28.1 32.7 20.3 13.8 39.5 24.0 73.2 36.3 52.5 25.0 40.8 25.1 25.5 33.4 31.5 27.7 36.5 38.3 34.5 29.5 21.2 37.0 28.1 26.9 39.3 32.9 38.8 38.2 37.6 34.7 31.8 36.4 36.5 21.9 32.4 35.6 48.5 42.4 27.3 32.8 40.7 20.2 37.7 30.1 20.4 40.0 26.2 35.8 35.6 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" 520000 "Nuclear membrane, Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: , CAB062552: , HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 31.2 11.8 8.2 9.0 7.4 14.9 14.7 15.4 16.5 19.7 20.7 10.5 6.1 24.9 23.5 15.8 17.4 15.6 19.1 8.4 14.6 34.1 11.7 17.4 6.2 20.2 11.2 12.9 13.0 15.2 17.6 21.9 13.7 9.6 10.8 13.4 13.3 19.6 20.6 13.7 37.0 16.3 12.2 23.7 10.6 6.0 10.4 12.9 8.0 13.4 18.8 9.3 8.4 12.3 9.8 18.7 22.1 22.1 35.1 26.0 44.9 11.9 19.0 10.6 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" "Lipid droplets" "Endoplasmic reticulum" "HPA065968: , HPA071246: , HPA073828: " "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavourable (1.79e-4)" "prognostic unfavourable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 21.1 27.7 17.5 16.5 28.5 21.7 20.8 25.4 28.3 21.5 19.2 24.4 17.4 17.2 22.3 21.5 23.0 21.0 18.0 15.1 16.8 18.9 20.5 34.2 17.8 17.2 16.4 15.9 29.3 25.9 32.4 31.5 32.0 25.5 22.3 23.1 24.6 20.1 18.6 15.3 25.5 22.6 22.2 14.5 21.0 18.8 31.9 14.2 30.0 23.1 15.2 24.3 20.7 17.5 7.2 10.9 10.0 14.9 12.4 13.1 7.5 13.9 15.9 15.8 17.5 22.4 17.9 21.6 18.3 21.0 20.9 22.7 20.6 25.3 12.2 20.7 19.3 21.6 22.6 46.4 29.0 48.6 12.4 8.0 16.2 10.0 22.9 17.3 10.5 23.5 20.5 25.5 21.3 17.3 11.4 16.7 19.9 23.2 15.1 9.2 12.7 13.5 15.0 13.7 13.6 17.7 18.5 14.0 15.0 22.3 19.4 20.2 22.8 13.8 19.3 28.8 15.6 15.8 24.4 14.4 15.3 16.0 18.2 12.4 25.1 10.0 9.2 6.1 10.0 7.6 12.2 7.2 8.2 10.5 10.9 7.0 10.7 9.5 7.8 12.4 14.9 7.5 13.1 7.5 17.5 28.5 25.4 28.3 16.8 18.9 16.4 15.9 25.5 14.2 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell line enhanced" "Detected in some" "Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favourable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.0 1.9 0.5 0.6 0.4 0.3 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.3 0.0 0.0 0.0 1.0 0.1 1.1 0.0 28.4 0.6 0.9 6.4 0.9 0.1 0.3 0.0 0.4 0.1 0.1 1.1 0.9 0.2 0.5 2.0 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 1.9 0.9 1.4 7.2 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142873-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "pancreas: 202.8" "Group enriched" "Detected in some" 5 "EFO-21: 37.1;U-2 OS: 52.8" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "pons and medulla: 3.7" "Region enhanced" "Detected in single" "midbrain: 2.0" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" 77950 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 1.0 0.1 0.2 0.6 0.2 1.1 0.2 0.2 1.8 0.2 6.6 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 3.4 0.2 0.2 0.2 0.2 0.2 0.2 202.8 0.0 0.2 0.2 0.5 0.2 12.6 0.2 0.2 0.2 0.2 2.5 11.0 0.2 0.2 0.2 2.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 2.9 0.0 1.4 8.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.5 0.2 GNPTG "C16orf27, c316G12.3, CAB56184, GNPTAG" ENSG00000090581 "N-acetylglucosamine-1-phosphate transferase gamma subunit" Q9UJJ9 16 1351923-1364113 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004055 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 420000000 "Endoplasmic reticulum" Cytosol "HPA004055: AB_1079006" "unprognostic (4.37e-2)" "unprognostic (2.20e-2)" "unprognostic (1.84e-1)" "unprognostic (9.57e-3)" "unprognostic (2.70e-3)" "unprognostic (2.09e-1)" "unprognostic (3.03e-2)" "unprognostic (3.66e-1)" "unprognostic (1.69e-1)" "unprognostic (3.29e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.14e-2)" "unprognostic (2.20e-1)" "unprognostic (2.31e-1)" "unprognostic (4.85e-2)" "unprognostic (2.07e-2)" 23.1 67.3 38.0 16.9 35.7 19.9 20.2 22.0 38.8 19.6 23.5 41.7 22.2 16.5 18.9 28.4 17.3 19.1 22.2 17.8 38.5 31.7 29.9 41.1 21.7 22.6 39.3 28.6 22.3 34.6 33.7 25.1 27.2 28.9 21.1 15.6 20.5 37.8 22.2 28.1 33.4 19.5 15.1 43.3 26.3 21.2 18.0 31.0 11.1 24.0 13.2 13.2 20.0 17.8 15.5 29.3 25.8 37.1 14.6 21.7 20.9 4.7 7.6 5.6 9.8 51.7 19.2 7.2 13.9 18.2 5.5 10.6 6.8 13.4 3.0 16.1 18.7 8.7 3.4 8.1 2.8 9.5 7.4 3.9 23.7 11.6 21.9 6.4 16.0 25.6 14.2 5.3 7.6 10.1 4.7 17.9 9.1 10.8 3.0 6.4 5.2 4.3 10.8 4.8 13.6 13.7 6.2 4.4 5.8 14.0 14.5 10.0 13.4 9.7 9.8 11.1 9.5 9.1 6.7 18.9 13.7 6.2 9.1 5.6 7.3 25.8 37.1 22.2 21.7 34.0 19.9 15.5 18.7 20.5 29.3 14.6 17.3 15.8 15.0 14.6 31.9 24.7 21.3 20.9 38.0 35.7 22.0 38.8 38.5 31.7 39.3 28.6 28.9 31.0 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728093-104859919 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 41.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: " "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.50e-4)" "unprognostic (1.75e-1)" 6.4 5.4 12.7 3.7 16.1 4.3 6.1 15.5 13.1 6.6 4.8 6.8 2.5 3.6 8.5 2.9 8.1 5.4 5.0 5.2 7.5 8.6 9.4 2.9 5.7 3.5 8.8 9.6 6.4 3.8 12.0 7.4 41.9 10.2 6.1 3.3 7.7 6.2 6.9 4.4 4.8 3.6 6.5 9.5 4.1 3.9 14.1 8.9 5.4 7.1 2.7 3.9 6.4 5.8 2.9 2.4 2.2 2.9 2.2 3.9 1.6 3.5 2.5 10.7 13.4 6.4 8.5 12.7 7.2 11.1 4.6 6.9 2.3 2.1 2.0 3.2 5.4 2.4 2.7 4.9 9.7 8.2 6.8 7.1 2.3 3.1 6.4 6.1 2.3 5.7 4.5 5.9 5.0 7.5 6.8 2.3 9.0 2.6 4.5 3.6 4.7 2.4 7.2 12.2 0.8 3.7 6.1 5.8 8.7 3.9 4.1 2.1 2.6 8.4 7.9 3.7 3.1 9.9 6.8 3.3 3.6 6.9 3.9 5.8 6.7 0.0 1.9 2.2 3.7 2.9 3.9 2.9 3.7 3.6 1.9 2.7 3.9 3.0 0.4 2.2 1.5 2.4 1.2 1.6 12.7 16.1 15.5 13.1 7.5 8.6 8.8 9.6 10.2 8.9 INF2 "C14orf151, C14orf173, MGC13251" ENSG00000203485 "Inverted formin, FH2 and WH2 domain containing" Q27J81 14 104689606-104722535 "Disease related genes, Predicted intracellular proteins" Actin-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 200.6" HPA000724 Approved Approved "Nuclear bodies,Endoplasmic reticulum" 15000000 "Endoplasmic reticulum" "Nuclear bodies" "HPA000724: AB_1078325" "unprognostic (1.42e-1)" "unprognostic (9.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.00e-2)" "unprognostic (1.49e-2)" "unprognostic (5.90e-3)" "prognostic unfavourable (8.18e-4)" "unprognostic (1.13e-2)" "unprognostic (9.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (1.36e-3)" "unprognostic (7.24e-2)" "unprognostic (4.01e-1)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.70e-2)" 34.7 13.1 14.4 17.8 49.9 12.7 20.2 4.4 37.9 13.3 27.0 70.2 6.1 43.1 12.8 6.3 12.5 9.3 26.5 14.1 19.7 12.6 17.9 21.3 22.2 15.0 66.2 22.5 7.7 14.8 4.1 4.7 28.0 28.5 13.2 13.2 18.8 15.4 16.3 10.0 23.9 36.5 10.7 36.8 24.4 48.2 18.1 54.6 3.2 11.7 9.8 9.1 16.8 15.5 3.1 11.0 2.3 3.3 2.0 5.3 4.8 17.2 35.2 3.2 7.8 6.5 8.4 46.5 19.0 9.9 10.5 7.8 12.8 38.7 2.5 21.1 13.5 26.2 3.9 18.6 4.0 7.3 9.5 8.9 24.2 12.7 13.5 2.8 8.6 7.9 10.5 10.0 6.9 12.4 4.3 8.8 9.8 39.0 3.3 7.0 7.9 37.6 14.6 10.5 6.8 13.1 23.5 9.0 4.2 15.4 29.3 9.9 10.0 6.4 21.9 13.2 9.2 25.3 10.6 3.1 1.4 1.3 22.7 7.8 14.2 1.3 3.3 0.2 1.6 1.1 0.8 3.1 5.3 1.1 4.1 3.1 4.4 2.9 2.3 2.0 0.7 11.0 5.3 4.8 14.4 49.9 4.4 37.9 19.7 12.6 66.2 22.5 28.5 54.6 ISOC1 CGI-111 ENSG00000066583 "Isochorismatase domain containing 1" Q96CN7 5 129094751-129114028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070307 Approved "Endoplasmic reticulum,Vesicles" 1500000 "Endoplasmic reticulum, Vesicles" "HPA070307: " "unprognostic (1.67e-1)" "unprognostic (4.46e-2)" "unprognostic (1.29e-1)" "unprognostic (6.42e-3)" "unprognostic (3.87e-2)" "unprognostic (1.91e-1)" "unprognostic (6.32e-2)" "unprognostic (1.90e-1)" "unprognostic (2.47e-1)" "unprognostic (4.19e-2)" "unprognostic (2.00e-2)" "unprognostic (4.18e-1)" "unprognostic (7.09e-3)" "unprognostic (2.49e-1)" "unprognostic (2.65e-1)" "unprognostic (1.65e-2)" "unprognostic (1.32e-2)" 10.5 13.1 9.2 8.9 9.7 4.1 20.7 2.2 8.4 26.3 14.6 7.5 2.1 12.8 44.3 9.0 17.1 13.6 6.4 48.6 7.3 14.2 13.7 40.3 7.1 10.3 11.3 9.5 14.7 22.0 6.8 18.0 7.5 11.2 9.2 9.1 5.4 19.0 3.8 6.6 11.4 19.6 27.1 11.5 5.8 7.9 5.5 9.2 10.4 9.3 11.2 10.2 8.2 10.9 23.2 15.6 24.2 12.8 26.9 32.8 22.0 8.5 6.8 7.0 10.8 11.6 6.2 31.2 3.7 3.2 4.3 7.6 23.7 12.2 6.1 9.3 2.1 4.7 14.9 11.2 7.9 33.5 17.0 12.2 6.9 17.3 8.2 4.8 4.4 4.0 3.4 6.6 5.8 10.1 13.2 10.7 3.7 34.3 8.9 7.8 10.8 18.6 12.9 20.6 6.0 10.6 17.5 12.0 51.3 10.7 13.6 6.7 11.2 4.0 4.2 4.8 9.2 3.8 12.0 9.0 7.0 10.2 5.4 15.2 5.4 24.2 12.8 18.1 28.5 12.2 31.9 23.2 26.8 30.0 15.6 21.1 23.7 27.9 15.9 26.9 11.5 14.2 32.8 22.0 9.2 9.7 2.2 8.4 7.3 14.2 11.3 9.5 11.2 9.2 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell line enhanced" "Detected in many" "TIME: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA059144: , HPA062260: " "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.6 1.1 1.6 2.6 4.9 5.0 1.7 2.5 3.4 1.7 1.8 0.1 1.4 9.2 1.6 3.3 2.9 8.6 5.2 2.3 2.2 2.8 7.4 2.4 14.8 4.5 6.6 3.3 4.7 0.7 3.7 6.8 16.3 3.2 2.9 2.2 2.2 4.6 8.8 7.1 0.8 1.5 3.8 5.8 4.0 4.2 0.5 2.6 11.2 2.0 6.2 4.2 3.3 35.6 3.5 1.3 3.4 3.1 2.7 2.1 17.2 3.2 3.0 2.2 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 KCTD20 "C6orf69, dJ108K11.3, MGC14254" ENSG00000112078 "Potassium channel tetramerization domain containing 20" Q7Z5Y7 6 36442767-36491143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030092 Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA030092: AB_10601437" "unprognostic (2.17e-1)" "unprognostic (2.02e-1)" "unprognostic (5.20e-3)" "unprognostic (2.43e-2)" "unprognostic (1.00e-3)" "unprognostic (5.03e-3)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.63e-1)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.22e-1)" "unprognostic (8.05e-2)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (9.31e-4)" "unprognostic (2.94e-2)" 34.3 23.1 18.4 22.8 17.6 20.1 39.0 15.7 21.4 22.2 20.7 18.7 22.4 12.0 25.5 23.1 24.6 22.0 25.1 21.0 16.3 17.1 16.2 29.7 20.5 26.2 18.0 14.4 25.6 12.7 15.7 16.1 21.7 16.5 17.5 16.0 17.9 16.2 19.2 20.4 24.6 17.6 30.8 17.3 24.2 16.6 10.2 13.3 31.6 13.6 18.1 24.9 21.5 18.3 6.2 14.0 19.4 14.4 6.4 8.5 10.9 10.9 5.0 14.5 27.7 19.9 12.8 7.0 13.3 18.4 14.5 16.2 12.8 6.2 36.8 12.0 21.6 10.1 18.9 9.6 24.1 26.2 10.4 20.9 7.9 13.5 9.3 20.2 14.6 12.9 10.0 11.1 7.1 14.8 32.3 21.1 13.6 9.6 23.0 7.7 5.4 4.5 22.9 16.5 20.7 7.8 12.3 3.5 20.5 11.6 11.8 35.4 16.3 20.2 16.8 39.3 13.5 11.6 16.5 16.7 38.7 26.7 6.8 28.0 40.1 19.4 14.4 9.2 7.5 13.1 8.5 6.2 5.9 6.2 14.0 5.1 6.2 6.1 10.6 6.4 7.2 7.6 6.9 10.9 18.4 17.6 15.7 21.4 16.3 17.1 18.0 14.4 16.5 13.3 LAMC1 LAMB2 ENSG00000135862 "Laminin subunit gamma 1" P11047 1 183023460-183145592 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 167.8;ASC TERT1: 92.4;HSkMC: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 15 "B-cells: 3.2;dendritic cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001908, HPA001909, CAB004486, CAB078163" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to extracellular matrix" 90000000 "Endoplasmic reticulum, Plasma membrane" "CAB004486: AB_627870, CAB078163: , HPA001908: AB_1079229, HPA001909: AB_1079230" "unprognostic (1.46e-1)" "unprognostic (1.05e-2)" "unprognostic (8.30e-2)" "unprognostic (8.84e-3)" "unprognostic (3.75e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-2)" "unprognostic (2.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-3)" "unprognostic (1.10e-3)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (8.85e-5)" 49.0 6.8 2.9 11.3 4.0 0.2 51.5 5.9 3.4 30.4 27.7 2.8 12.8 4.9 30.5 28.7 31.5 21.5 25.9 39.5 3.4 2.0 10.0 6.8 22.5 10.6 3.9 2.7 22.7 9.8 7.4 4.1 73.1 3.5 23.9 11.4 11.7 11.6 17.3 32.2 15.6 17.6 41.3 3.0 4.7 22.3 16.1 2.7 3.5 21.7 16.4 7.3 40.2 37.6 3.2 1.3 0.0 0.1 0.0 0.0 0.2 5.1 8.4 27.7 7.8 167.8 92.4 42.0 38.0 38.2 15.3 9.1 24.9 5.9 1.8 17.6 18.2 12.9 5.2 10.0 11.8 0.0 5.3 0.0 7.6 9.0 26.4 1.6 0.9 104.0 5.4 18.3 14.5 26.7 0.0 5.7 18.6 2.2 0.0 1.7 11.2 1.6 1.3 23.4 0.9 24.8 13.7 1.8 5.2 10.0 0.0 9.7 2.1 4.3 49.2 18.8 7.4 17.3 9.5 2.2 0.0 1.2 15.5 1.2 18.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 2.9 4.0 5.9 3.4 3.4 2.0 3.9 2.7 3.5 2.7 LCLAT1 "AGPAT8, ALCAT1, FLJ37965, LYCAT" ENSG00000172954 "Lysocardiolipin acyltransferase 1" Q6UWP7 2 30447226-30644225 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031880, HPA049217" Uncertain Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA031880: AB_10610002, HPA049217: " "unprognostic (6.60e-2)" "unprognostic (2.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.52e-3)" "unprognostic (4.10e-1)" "prognostic unfavourable (9.67e-4)" "prognostic unfavourable (8.72e-4)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-2)" "unprognostic (7.11e-3)" "unprognostic (2.85e-2)" "unprognostic (4.14e-2)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (3.93e-3)" "unprognostic (1.10e-1)" 7.7 9.7 7.0 13.7 8.7 12.3 7.1 10.2 10.1 11.6 10.7 5.2 12.6 15.7 18.7 15.0 13.0 9.9 12.6 21.7 7.5 9.2 15.2 13.8 10.0 12.5 6.1 6.0 15.4 16.7 10.8 21.8 5.7 7.0 10.7 10.6 9.7 9.5 16.3 10.9 9.4 25.0 11.3 5.5 8.0 8.4 12.1 4.2 20.7 17.9 11.9 11.7 9.1 10.4 9.6 2.8 10.5 3.9 4.1 12.6 2.8 10.9 14.6 7.9 13.3 1.8 4.2 11.2 8.0 7.9 8.5 7.2 14.6 13.0 7.1 7.4 12.3 12.5 26.0 10.7 8.4 8.9 8.9 13.0 9.1 14.1 8.4 18.4 10.0 3.2 8.5 9.0 12.5 5.9 11.9 6.8 6.5 8.5 10.5 10.9 8.6 8.4 10.3 15.8 14.5 6.7 16.2 9.2 14.2 17.8 11.9 10.3 8.6 6.3 6.7 15.5 12.8 8.2 12.5 4.9 10.2 16.0 15.8 13.5 11.8 10.5 2.5 4.8 5.6 3.9 6.6 7.5 8.7 7.1 2.8 9.6 12.6 12.1 7.4 4.1 3.5 2.2 4.0 2.8 7.0 8.7 10.2 10.1 7.5 9.2 6.1 6.0 7.0 4.2 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;NTERA-2: 5.9;U-2 OS: 16.6;U-251 MG: 7.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" "Plasma membrane" "Endoplasmic reticulum" "HPA071640: " "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.1 0.4 0.4 0.4 0.5 6.4 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.6 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 0.4 0.4 0.2 0.1 0.3 0.4 5.9 0.1 0.2 3.5 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 0.4 0.5 0.4 1.7 16.6 0.6 7.0 0.2 0.2 0.2 2.2 0.7 3.0 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 LNPK "KIAA1715, LNP, LNP1, Ul" ENSG00000144320 "Lunapark, ER junction formation factor" Q9C0E8 2 175923892-176002839 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014205 Approved Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA014205: AB_2234186" "unprognostic (4.93e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-2)" "unprognostic (8.73e-2)" "unprognostic (1.27e-1)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (3.13e-1)" "unprognostic (4.17e-3)" "unprognostic (1.63e-1)" "unprognostic (9.27e-2)" "unprognostic (2.35e-3)" "unprognostic (3.43e-2)" 14.2 10.8 13.4 8.4 16.0 29.4 11.3 12.9 26.5 15.0 13.3 13.4 7.1 8.6 11.9 7.7 15.1 8.2 9.1 13.6 13.8 16.1 9.8 16.3 8.1 7.6 19.9 14.2 12.8 6.4 16.8 22.8 9.4 21.1 12.0 11.9 10.1 8.6 10.1 33.5 13.5 8.4 11.3 26.2 6.6 8.9 25.4 14.6 16.4 10.3 14.8 8.7 12.2 15.1 7.1 6.7 11.6 7.3 9.7 11.6 5.2 8.5 4.3 10.3 14.6 21.8 13.6 5.1 25.3 12.2 11.8 16.7 6.0 10.1 8.6 14.5 11.2 9.5 9.7 6.7 16.5 13.0 9.9 9.7 5.6 5.3 5.1 16.4 12.0 11.2 6.4 11.5 5.7 2.1 9.9 11.5 16.2 5.6 10.8 6.5 3.3 8.4 10.9 10.4 6.3 5.0 7.9 11.9 12.1 11.1 6.4 8.5 9.5 5.4 3.2 58.8 8.7 19.6 11.8 6.8 12.4 7.1 18.2 5.4 10.9 5.7 6.6 11.6 8.1 7.3 9.5 7.1 7.2 8.9 6.0 5.0 7.2 11.2 5.6 9.7 6.7 6.7 11.6 5.2 13.4 16.0 12.9 23.3 13.8 16.1 19.9 14.2 21.1 14.6 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell line enhanced" "Detected in many" "BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavourable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavourable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favourable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavourable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.2 0.3 0.5 34.2 7.7 0.4 0.4 0.3 1.1 0.9 6.7 32.9 0.2 5.7 0.6 0.2 0.2 16.2 13.9 1.6 4.8 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.4 3.6 1.2 0.0 4.2 6.3 2.6 12.0 22.9 12.0 0.5 4.9 1.3 2.7 4.3 4.2 6.1 5.5 1.8 2.6 2.6 3.8 0.6 7.5 2.3 2.7 4.3 4.1 1.5 1.4 2.8 2.0 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 LPCAT2 "AGPAT11, AYTL1, FLJ20481, LysoPAFAT" ENSG00000087253 "Lysophosphatidylcholine acyltransferase 2" Q7L5N7 16 55508998-55586670 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.5;HaCaT: 25.7;HL-60: 28.7;HMC-1: 47.8;WM-115: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.8;eosinophil: 49.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007891, HPA008433" Enhanced Supported Supported "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA007891: AB_1845223, HPA008433: " "unprognostic (1.43e-1)" "unprognostic (2.44e-2)" "prognostic favourable (3.43e-4)" "prognostic favourable (8.03e-6)" "unprognostic (2.91e-1)" "unprognostic (9.65e-3)" "unprognostic (8.12e-3)" "unprognostic (3.26e-3)" "unprognostic (1.67e-1)" "unprognostic (7.97e-2)" "unprognostic (3.18e-3)" "unprognostic (9.16e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" 10.5 7.5 10.5 8.0 16.2 43.5 9.9 1.7 7.5 11.0 5.2 18.2 36.5 4.3 17.0 21.5 7.2 8.5 6.2 5.7 9.6 6.3 6.7 2.4 7.4 10.3 18.6 3.1 11.0 3.8 12.7 1.9 9.0 16.1 8.2 5.5 5.1 7.7 33.2 3.0 10.2 5.4 8.9 30.7 8.9 5.3 4.6 14.9 0.9 49.0 5.2 2.6 8.5 8.5 0.0 5.4 49.4 9.3 0.0 0.0 1.4 9.4 1.2 1.0 0.1 3.3 1.2 1.7 4.0 3.9 2.0 2.0 2.1 33.5 0.0 13.8 5.7 25.7 0.6 5.5 3.2 2.5 2.8 9.6 3.1 4.9 1.2 28.7 47.8 0.6 5.6 2.2 1.8 15.4 0.4 0.1 3.3 0.6 0.0 11.6 1.5 0.1 2.9 1.1 1.4 1.9 3.7 0.6 7.4 7.7 3.1 5.6 1.3 7.3 17.3 0.3 0.0 2.0 2.7 0.1 0.0 0.0 0.8 14.0 34.0 28.8 4.5 49.4 0.0 6.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 12.1 0.0 9.3 0.1 0.0 1.4 10.5 16.2 1.7 7.5 9.6 6.3 18.6 3.1 16.1 14.9 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.6 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.3 16.1 0.0 0.1 0.0 0.1 1.9 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavourable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.0 0.1 0.0 0.2 0.1 0.0 4.6 0.4 1.1 0.4 0.5 0.1 12.5 0.0 0.5 0.3 29.4 0.0 1.3 0.2 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.1 0.0 0.1 0.0 0.0 0.0 0.0 32.8 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.3 31.5 0.0 0.0 0.1 47.3 0.5 5.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 MARCH2 "HSPC240, MARCH-II, RNF172" ENSG00000099785 "Membrane associated ring-CH-type finger 2" Q9P0N8 19 8413270-8439017 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014063 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" Cytosol "HPA014063: AB_1853576" "unprognostic (1.15e-2)" "unprognostic (4.01e-3)" "prognostic unfavourable (6.48e-4)" "prognostic favourable (1.05e-5)" "unprognostic (3.00e-1)" "prognostic favourable (8.29e-4)" "unprognostic (3.43e-2)" "unprognostic (6.95e-2)" "unprognostic (3.06e-3)" "unprognostic (2.32e-1)" "prognostic favourable (6.21e-4)" "unprognostic (2.01e-1)" "unprognostic (3.52e-1)" "unprognostic (1.01e-1)" "unprognostic (3.16e-1)" "unprognostic (9.91e-2)" "unprognostic (1.80e-2)" 37.7 12.4 30.7 13.5 28.3 17.5 23.9 8.6 39.1 9.8 29.8 20.7 9.7 11.2 12.5 39.0 19.3 10.0 11.4 38.9 23.5 21.9 11.0 17.9 18.2 15.0 30.8 19.8 8.2 10.0 10.5 11.3 13.9 20.2 16.0 10.3 12.7 13.4 21.8 46.9 12.7 11.7 28.5 27.8 18.9 13.3 8.6 13.3 8.4 21.3 14.1 10.0 20.4 9.7 3.6 26.5 20.4 14.6 3.7 7.3 10.1 5.4 7.0 3.2 14.7 19.5 6.4 5.4 6.0 7.3 4.8 5.0 3.4 2.6 2.2 17.6 12.8 3.9 4.1 8.4 3.7 10.9 9.7 16.7 3.3 7.6 10.5 2.4 25.1 7.6 9.7 4.6 4.1 18.7 2.3 12.3 3.7 10.5 3.3 7.9 6.6 17.0 5.3 1.0 5.5 11.0 6.5 1.6 8.9 0.4 6.4 11.3 4.9 5.2 18.8 6.7 4.1 22.3 5.0 11.0 13.0 2.5 10.9 5.0 5.1 20.4 10.0 15.4 5.7 14.6 5.9 3.6 5.9 4.6 6.7 3.5 4.0 5.4 12.5 3.7 12.8 26.5 7.3 10.1 30.7 28.3 8.6 39.1 23.5 21.9 30.8 19.8 20.2 13.3 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Cell line enriched" "Detected in many" 6 "Hep G2: 55.1" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.9;hypothalamus: 3.2" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" "Endoplasmic reticulum, Golgi apparatus" "HPA051250: " "unprognostic (3.47e-1)" "prognostic unfavourable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavourable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavourable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 1.9 6.4 0.0 1.8 4.0 0.4 0.7 0.4 2.6 3.3 1.8 1.0 0.0 0.3 0.6 0.4 0.1 4.9 3.7 0.0 0.1 0.0 0.4 55.1 0.4 0.0 0.0 8.7 0.3 2.8 0.6 3.4 0.0 0.0 5.4 0.9 0.0 0.0 1.9 0.9 0.0 0.0 0.0 7.8 1.7 0.0 0.8 4.1 0.7 2.4 7.6 0.0 1.9 3.8 4.7 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell line enhanced" "Detected in many" "ASC diff: 335.0;ASC TERT1: 129.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favourable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.0 7.1 8.3 335.0 129.3 0.0 24.6 25.2 13.4 20.9 11.3 50.2 0.0 3.0 31.4 0.1 18.6 39.3 12.2 0.0 2.5 10.2 16.6 39.9 78.3 19.8 0.0 83.9 43.9 40.9 43.2 23.5 7.2 0.0 28.8 6.1 0.0 8.0 59.7 23.8 0.0 4.2 13.5 30.2 59.3 1.3 1.0 38.4 24.6 1.0 26.6 11.2 14.8 13.8 1.8 27.1 31.7 0.0 0.0 0.0 45.5 31.6 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.7" "Cell line enriched" "Detected in many" 6 "BEWO: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 16 "classical monocyte: 3.2;myeloid DC: 1.0" "Group enriched" "Detected in many" 16 "dendritic cells: 1.0;monocytes: 3.2" "Region enriched" "Detected in single" 6 "olfactory region: 8.8" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" 800000 "Endoplasmic reticulum, Vesicles" "HPA070804: " "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavourable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 60.7 1.9 0.2 10.9 0.7 0.0 9.9 0.2 0.5 7.6 3.9 0.4 1.4 0.8 12.7 6.0 3.6 11.8 30.3 4.7 0.6 0.1 4.1 3.0 14.0 15.5 0.5 0.2 7.4 8.1 0.0 0.5 24.5 1.0 2.9 2.8 3.1 2.0 3.5 2.1 2.7 4.1 7.7 0.8 27.4 5.0 2.9 0.2 2.7 3.3 1.8 7.1 5.9 3.5 0.0 1.0 0.1 3.2 0.0 0.0 0.6 0.8 0.0 0.0 0.0 6.2 7.9 55.9 5.9 6.9 2.4 2.8 0.3 0.2 0.0 0.0 8.2 0.0 0.0 1.8 3.3 0.3 0.0 0.0 0.0 0.1 5.1 0.0 0.2 8.2 0.2 1.5 1.5 0.4 0.1 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 1.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 1.5 3.3 0.0 0.2 0.0 0.0 0.0 4.3 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.7 0.2 0.5 0.6 0.1 0.5 0.2 1.0 0.2 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.3 25.8 18.8 12.4 23.9 21.9 11.4 20.4 30.0 38.7 28.5 13.4 20.8 7.3 14.8 35.3 23.9 28.5 35.0 33.0 15.3 26.1 13.4 17.1 22.9 29.8 11.1 20.8 22.3 28.9 36.1 21.4 29.3 21.8 9.5 41.9 17.6 7.3 6.9 20.3 12.2 16.9 14.6 12.5 38.8 12.1 11.8 21.5 26.6 18.5 7.0 21.6 9.0 19.7 16.0 8.2 9.3 25.4 4.8 8.8 6.1 22.9 14.4 22.7 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 MSH5 G7 ENSG00000204410 "MutS homolog 5" O43196 6 31739948-31762834 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 9.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.3" HPA062688 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA062688: " "unprognostic (3.21e-3)" "unprognostic (2.32e-2)" "unprognostic (2.05e-1)" "unprognostic (4.37e-2)" "unprognostic (4.51e-1)" "unprognostic (9.20e-4)" "unprognostic (7.67e-3)" "unprognostic (2.57e-2)" "unprognostic (1.45e-2)" "unprognostic (2.05e-3)" "unprognostic (4.59e-3)" "unprognostic (2.28e-2)" "unprognostic (5.19e-5)" "unprognostic (3.75e-2)" "unprognostic (8.83e-2)" "unprognostic (9.21e-2)" "unprognostic (9.34e-4)" 3.6 2.7 3.2 8.0 4.4 6.8 4.1 1.6 4.4 3.9 5.8 6.9 9.3 3.0 9.8 8.5 4.7 5.8 15.2 2.0 3.2 2.1 10.5 4.7 4.3 5.7 4.0 3.6 6.9 4.0 1.6 6.5 3.0 4.1 7.9 5.3 12.4 4.7 9.2 2.3 12.3 5.2 6.0 5.7 7.6 6.8 15.9 3.8 12.0 4.3 2.7 10.6 3.6 4.0 1.0 0.5 9.3 0.9 0.1 0.8 0.0 2.0 1.9 2.3 4.7 0.8 0.7 0.7 0.6 0.2 0.8 0.3 1.2 2.6 2.5 0.7 0.5 2.9 0.0 1.2 0.3 0.4 1.1 2.4 0.6 1.4 0.3 1.9 1.9 0.8 0.5 1.9 2.4 0.9 4.8 6.0 0.7 2.6 3.6 4.1 0.9 0.4 1.3 1.0 3.9 1.4 0.4 0.6 2.4 0.8 0.0 0.0 1.3 2.7 0.7 1.7 3.5 0.0 1.5 2.7 1.0 2.8 0.7 3.9 3.6 9.3 0.4 0.0 0.7 0.3 0.2 1.0 0.4 0.2 0.2 0.5 0.1 0.0 0.0 0.1 0.9 0.5 0.8 0.0 3.2 4.4 1.6 4.4 3.2 2.1 4.0 3.6 4.1 3.8 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favourable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favourable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 17.4 24.8 11.0 7.7 10.5 6.0 20.4 7.7 15.0 13.4 23.4 13.9 20.5 13.3 10.4 35.7 36.2 11.9 7.4 16.7 14.3 11.4 11.6 38.1 9.9 8.7 9.7 10.4 9.8 7.9 9.8 6.9 7.9 18.9 12.0 10.7 7.9 12.2 17.7 6.9 14.5 24.0 9.9 14.2 7.3 9.6 8.6 9.3 6.0 11.0 22.2 17.0 7.5 16.1 16.2 17.5 16.4 17.7 17.0 17.3 13.0 43.6 16.1 21.9 11.4 18.9 14.4 12.4 8.7 11.7 15.9 20.3 22.2 23.9 21.6 29.4 11.8 22.5 28.5 40.2 14.1 7.2 16.3 8.8 15.7 22.4 13.8 8.8 7.2 17.6 15.6 31.1 7.9 14.7 14.6 9.8 12.0 19.3 8.7 11.5 8.7 19.4 6.5 15.9 17.7 33.0 18.1 7.9 9.0 7.8 11.7 9.2 7.7 11.3 12.4 7.4 12.3 17.8 16.7 13.9 9.3 37.2 13.7 13.8 7.0 16.4 17.7 15.8 15.6 16.2 15.7 16.2 15.6 13.5 17.5 12.9 11.4 12.6 1.9 17.0 12.1 15.6 17.3 13.0 11.0 10.5 7.7 15.0 14.3 11.4 9.7 10.4 18.9 9.3 OMD "osteoadherin, SLRR2C" ENSG00000127083 Osteomodulin Q99983 9 92414245-92424461 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 14 "ASC diff: 12.3;ASC TERT1: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069948 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Secreted in other tissues" 14000000 "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA069948: " "unprognostic (1.18e-1)" "unprognostic (2.33e-3)" "unprognostic (5.04e-2)" "unprognostic (2.26e-1)" "unprognostic (9.42e-2)" "unprognostic (1.87e-2)" "unprognostic (4.31e-3)" "unprognostic (6.42e-2)" "unprognostic (4.53e-1)" "unprognostic (3.89e-2)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-3)" "unprognostic (6.35e-2)" "unprognostic (2.84e-3)" "unprognostic (2.08e-3)" 14.0 7.9 2.2 1.2 4.3 0.0 14.6 3.7 3.4 20.3 8.3 1.0 8.0 0.8 8.2 19.3 14.0 8.7 8.9 20.2 2.8 1.7 2.9 0.8 12.2 0.8 7.0 5.4 15.3 1.8 1.5 4.2 11.5 6.0 13.6 2.2 14.2 2.3 4.2 2.8 3.5 3.7 13.9 19.3 0.7 5.0 12.8 1.3 0.2 9.2 14.5 3.2 22.1 7.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 12.3 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.2 4.3 3.7 3.4 2.8 1.7 7.0 5.4 6.0 1.3 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 61.3;U-87 MG: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavourable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavourable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.1 6.2 2.0 9.9 27.9 33.3 11.3 47.5 40.6 20.2 50.0 14.0 8.9 0.2 14.0 50.8 12.8 6.2 24.8 32.0 7.5 2.1 0.0 9.1 8.4 61.3 0.0 6.1 20.1 36.7 23.9 22.0 10.6 3.6 0.6 24.7 4.0 0.0 0.0 0.5 5.1 0.1 0.6 1.5 5.6 1.9 1.0 2.8 12.1 4.0 8.0 5.0 0.7 16.3 30.7 12.0 9.3 10.2 4.3 4.6 2.0 59.2 0.0 8.5 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836885-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 65.1;liver: 220.0" "Cell line enriched" "Detected in some" 31 "Hep G2: 71.1" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favourable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 1.3 0.5 0.0 0.5 0.0 0.1 0.2 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 20.3 0.1 0.8 0.3 65.1 220.0 0.0 0.0 0.3 0.7 0.1 1.7 0.0 1.6 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 1.0 0.8 0.3 0.3 0.7 0.8 0.4 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 20.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 4.5 2.2 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 20.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 53000000 "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavourable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (1.20e-4)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 26.9 32.7 16.7 25.0 29.9 19.9 28.7 11.3 16.8 33.4 26.1 13.9 53.7 20.4 30.4 76.1 27.1 25.5 22.4 32.7 14.2 13.9 42.1 118.4 30.4 36.3 17.8 12.7 26.5 141.6 24.9 23.3 39.5 19.0 22.6 30.1 14.6 53.4 45.0 15.7 16.1 28.4 26.5 14.3 35.1 30.9 12.4 19.5 18.1 97.9 20.1 29.7 21.9 30.6 45.2 61.0 52.0 46.2 51.5 52.2 59.7 33.9 36.9 52.9 82.9 68.1 58.9 94.0 82.7 76.8 43.4 58.5 52.3 67.1 55.2 58.2 80.8 27.9 39.7 69.2 46.7 43.2 31.3 44.7 28.9 84.9 73.7 45.8 33.6 42.5 53.2 42.0 75.8 97.8 38.4 119.1 42.8 40.2 17.6 47.5 44.1 29.2 42.3 53.9 99.9 61.8 41.1 33.9 67.9 32.6 47.8 46.4 16.9 77.7 48.0 40.8 52.1 36.7 47.8 112.4 69.3 35.8 55.1 57.6 57.0 52.0 44.4 20.5 47.5 46.2 52.2 45.2 37.7 44.7 48.6 33.1 18.4 31.0 8.1 51.5 33.9 61.0 37.7 59.7 16.7 29.9 11.3 16.8 14.2 13.9 17.8 12.7 19.0 19.5 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Enhanced "Nucleoli,Endoplasmic reticulum" 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 26.8 17.0 33.4 38.4 72.2 34.7 21.7 40.6 47.3 21.6 26.9 20.5 33.0 7.7 44.5 42.1 21.5 36.4 17.0 29.1 8.2 41.8 8.7 16.3 23.0 12.0 14.3 4.7 35.7 9.6 26.2 13.6 13.9 9.2 4.8 25.3 28.7 10.7 10.5 87.5 28.7 12.8 20.9 11.2 28.5 20.5 31.2 13.9 29.7 49.4 15.9 11.4 9.2 10.7 15.1 22.2 53.2 38.2 5.1 9.3 8.4 41.1 22.8 28.6 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 PIGV FLJ20477 ENSG00000060642 "Phosphatidylinositol glycan anchor biosynthesis class V" Q9NUD9 1 26787472-26798398 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054181 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA054181: " "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.02e-2)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (8.40e-2)" "unprognostic (4.44e-2)" "prognostic favourable (7.60e-7)" "unprognostic (1.71e-1)" "unprognostic (4.24e-1)" "unprognostic (8.92e-2)" "unprognostic (5.96e-3)" 6.2 14.6 8.1 5.3 8.9 4.6 9.2 6.1 10.3 10.5 7.5 9.9 9.3 7.3 8.3 14.7 8.7 10.6 8.9 4.4 7.2 6.6 10.6 24.6 6.8 5.1 11.6 6.8 9.0 13.5 15.8 13.5 9.3 9.7 11.5 8.4 6.6 9.9 10.6 5.0 10.1 10.7 7.1 7.5 7.2 7.7 31.3 10.0 7.2 20.0 8.2 7.8 9.3 7.6 8.3 9.7 23.5 12.9 18.0 19.1 9.2 9.3 5.6 4.5 3.9 8.8 10.9 3.8 6.5 15.3 6.1 7.5 3.1 19.3 5.5 5.9 8.0 16.7 2.4 7.5 7.6 9.4 4.0 4.8 7.5 7.7 9.9 8.8 12.0 11.2 31.2 8.4 10.3 4.6 8.8 8.9 11.0 5.2 4.3 5.0 6.8 4.5 3.1 5.3 10.5 9.7 2.4 6.5 3.5 6.3 3.2 6.2 10.8 4.4 7.7 11.1 4.8 5.4 2.2 3.1 2.1 3.0 9.1 9.4 6.5 23.5 10.3 7.7 13.3 10.1 19.1 7.4 9.0 13.0 9.7 8.3 9.1 11.1 12.5 18.0 12.9 3.8 7.7 9.2 8.1 8.9 6.1 10.3 7.2 6.6 11.6 6.8 9.7 10.0 PLD3 HU-K4 ENSG00000105223 "Phospholipase D family member 3" Q8IV08 19 40348456-40380439 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 149.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012800, CAB020812" Approved Supported "Endoplasmic reticulum,Cytosol" 490000 "Endoplasmic reticulum, Cytosol" "CAB020812: , HPA012800: AB_1855330" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.64e-3)" "unprognostic (2.56e-3)" "unprognostic (2.06e-3)" "unprognostic (2.68e-1)" "unprognostic (4.52e-2)" "unprognostic (3.89e-2)" "unprognostic (1.09e-1)" "unprognostic (4.60e-2)" "prognostic favourable (6.44e-4)" "unprognostic (4.34e-2)" "prognostic favourable (2.21e-4)" "unprognostic (3.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (6.42e-2)" 45.7 57.5 44.6 23.1 79.0 12.8 21.9 35.5 126.1 31.2 23.5 25.4 17.1 22.6 26.3 35.0 18.3 30.0 30.8 33.0 46.4 73.4 22.1 25.6 49.7 25.2 44.7 53.9 44.8 42.5 32.9 122.1 38.9 62.2 29.6 16.1 31.6 35.3 37.2 27.4 24.2 23.5 25.6 28.6 48.9 23.0 17.0 19.3 11.9 20.6 11.2 12.9 27.3 20.7 3.6 23.0 149.2 24.6 9.7 7.8 16.8 13.9 43.2 28.0 44.0 77.9 37.1 21.3 34.7 35.4 25.2 28.9 8.2 15.8 6.1 36.4 30.1 6.5 6.7 13.6 11.0 22.6 24.6 6.5 14.8 10.3 53.2 2.7 75.0 70.6 28.5 19.2 13.2 21.1 23.0 24.6 18.1 18.3 4.7 13.0 18.2 8.9 6.0 21.3 24.9 12.9 10.5 20.1 33.4 16.6 10.3 18.5 14.2 47.0 37.2 21.3 10.2 18.0 7.7 25.6 27.3 6.3 34.2 10.9 13.1 149.2 24.6 35.3 7.8 12.8 6.4 3.6 6.2 6.9 23.0 3.1 6.5 6.5 2.5 9.7 5.7 3.3 6.1 16.8 44.6 79.0 35.5 126.1 46.4 73.4 44.7 53.9 62.2 19.3 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 431.8" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: " "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favourable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.4 0.0 6.5 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 431.8 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468938-119494708 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" "Endoplasmic reticulum" Cytosol "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favourable (2.23e-4)" 11.9 12.1 7.6 10.7 12.0 3.9 10.9 13.9 10.6 10.1 9.5 9.8 27.4 5.9 13.7 11.7 9.3 10.1 6.9 8.3 7.3 8.9 8.3 10.3 9.1 14.3 15.0 5.6 10.5 29.2 12.1 14.5 11.5 10.9 9.4 10.9 8.7 7.8 25.7 5.1 14.0 12.1 15.2 14.0 14.9 8.2 4.7 8.9 11.7 8.6 4.1 15.6 10.6 10.2 9.9 14.3 9.4 11.5 19.8 16.0 10.3 7.4 5.0 8.7 9.6 22.0 12.6 6.2 11.9 12.2 9.7 13.3 8.1 4.9 11.5 16.2 15.0 8.8 11.6 11.8 15.4 9.9 7.5 13.5 7.9 8.8 14.3 14.8 15.9 12.9 7.7 9.6 13.5 11.0 7.3 14.1 9.8 7.5 8.4 14.3 8.9 9.2 8.4 8.8 16.9 8.4 9.6 9.5 14.6 5.7 3.6 9.2 9.5 12.4 13.9 9.5 5.9 2.8 6.1 19.4 16.8 15.7 8.3 15.0 13.4 1.9 11.5 9.4 12.0 10.8 13.8 9.9 13.6 12.5 14.3 7.0 16.0 15.2 0.9 19.8 7.0 8.0 14.7 10.3 7.6 12.0 13.9 10.6 7.3 8.9 15.0 5.6 10.9 8.9 PPIB "CYPB, OI9" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155812-64163205 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Isomerase, Rotamase" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" 120000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favourable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavourable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 56.9 64.3 23.9 49.3 26.9 54.9 48.1 15.1 32.1 75.3 44.1 35.4 102.8 42.0 64.2 106.9 48.0 54.8 58.1 44.5 23.8 27.3 89.5 285.9 57.2 63.8 29.7 19.6 67.5 193.7 26.7 71.8 120.2 27.5 51.0 47.7 36.2 123.3 95.4 19.5 33.1 57.5 54.3 30.7 78.0 47.7 27.2 29.5 53.7 154.3 45.7 69.1 49.2 51.7 63.5 191.6 41.0 51.1 44.9 71.6 87.1 39.3 49.5 44.7 101.6 156.7 91.0 39.3 94.0 123.5 74.4 88.5 71.2 73.1 37.6 76.4 145.5 64.2 81.7 63.1 38.4 23.8 30.8 53.0 54.7 93.1 164.3 52.9 48.0 83.8 68.1 43.4 105.8 89.8 37.0 131.0 56.4 62.8 16.1 81.1 39.0 31.8 30.9 47.5 191.8 77.2 61.4 25.3 39.9 43.0 74.0 68.4 44.2 161.8 55.2 74.4 61.7 41.6 63.4 71.2 68.9 39.5 69.5 85.2 74.2 41.0 51.1 33.9 71.6 39.2 71.5 63.5 50.5 58.1 67.4 38.0 33.0 44.2 25.5 44.9 25.2 191.6 40.1 87.1 23.9 26.9 15.1 32.1 23.8 27.3 29.7 19.6 27.5 29.5 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071156-49074071 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 125.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: " "unprognostic (1.50e-1)" "prognostic favourable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavourable (1.66e-6)" "prognostic favourable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favourable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavourable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 13.5 17.5 25.0 12.3 26.9 6.7 9.0 18.0 39.7 28.1 11.8 26.3 12.6 6.0 22.1 125.1 7.3 15.6 12.3 12.9 25.3 29.9 12.4 6.9 11.5 11.3 26.1 18.9 20.1 6.2 19.7 31.0 9.8 25.5 12.2 10.0 13.0 7.5 29.4 6.8 7.6 6.6 33.2 23.1 10.9 9.2 17.7 17.0 14.4 13.3 3.8 11.9 12.6 10.7 14.6 6.7 16.4 6.4 16.8 29.4 11.1 4.5 9.5 11.1 14.1 40.0 24.3 1.4 16.1 16.9 11.0 12.1 0.5 1.4 0.4 3.9 34.9 4.2 0.4 8.7 12.2 8.3 12.6 3.6 12.3 0.4 41.0 2.3 7.0 30.9 7.5 20.8 15.2 16.8 0.5 1.2 19.1 8.3 14.9 2.8 6.2 0.6 8.2 6.1 0.9 16.3 1.3 7.4 18.5 13.5 7.0 9.2 6.8 1.6 10.1 8.5 11.3 18.2 4.7 20.1 5.1 3.6 20.4 4.1 13.1 16.4 5.9 7.9 18.3 6.4 20.7 14.6 20.1 16.1 6.7 13.6 18.1 19.4 15.4 16.8 4.8 2.6 29.4 11.1 25.0 26.9 18.0 39.7 25.3 29.9 26.1 18.9 25.5 17.0 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686399 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 127.6;pancreas: 320.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" 11000000 "Endoplasmic reticulum, Cytosol" "CAB008659: AB_1620984, CAB027389: , CAB047362: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 11.6 14.8 3.8 7.0 6.4 3.9 11.2 3.3 5.4 13.2 10.7 6.5 17.4 8.9 11.5 10.5 13.1 9.6 12.9 17.6 3.8 4.0 11.8 127.6 8.9 16.9 7.2 4.0 14.6 320.8 6.1 15.8 21.9 7.4 9.3 11.4 8.0 25.4 14.1 7.8 7.2 10.6 8.8 8.1 12.6 12.8 25.2 6.1 4.7 12.0 10.0 15.0 10.8 8.7 27.9 31.4 2.0 39.3 24.1 22.7 21.3 24.2 33.5 14.2 27.4 77.4 39.6 20.0 32.7 35.7 29.7 43.4 35.1 30.6 20.9 15.4 42.4 29.4 40.8 20.3 28.5 12.7 78.5 14.8 29.6 44.3 32.3 19.0 14.1 41.9 26.3 28.9 29.0 37.2 28.5 77.1 27.4 36.1 9.7 29.8 49.0 49.2 13.5 35.5 117.8 26.5 8.5 20.8 17.7 30.1 35.8 24.1 37.8 24.3 24.5 21.2 14.0 54.7 24.5 25.3 30.6 22.3 38.0 24.7 30.2 1.7 20.6 2.0 17.8 32.2 21.8 27.9 22.7 18.6 31.4 16.2 16.4 16.7 1.5 24.1 39.3 22.0 22.1 21.3 3.8 6.4 3.3 5.4 3.8 4.0 7.2 4.0 7.4 6.1 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1708 "pancreas: 3057.4" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7" "Low lineage specificity" "Detected in many" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 26000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: , HPA063471: " "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavourable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favourable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favourable (4.91e-4)" "unprognostic (3.12e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3057.4 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 1.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 1.5 0.0 2.5 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 708 "pancreas: 6267.9" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 37.2" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Group enriched" "Detected in some" 6 "basophil: 5.6;T-reg: 5.1" "Group enriched" "Detected in many" 6 "granulocytes: 5.6;T-cells: 5.1" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 27000000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "prognostic favourable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6267.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.6 0.0 0.7 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.5 2.1 0.0 1.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.3 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750466-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "pancreas: 984.9" "Cell line enriched" "Detected in some" 8 "PC-3: 121.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 82 "basophil: 39.0" "Lineage enriched" "Detected in single" 82 "granulocytes: 39.0" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" 490000000 Vesicles "Endoplasmic reticulum" "HPA062452: , HPA063471: " "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 0.3 0.3 1.6 1.7 1.5 0.2 0.2 2.8 4.2 0.9 8.2 0.0 0.0 2.8 0.2 0.2 2.9 0.2 4.8 0.4 1.2 0.7 0.3 0.4 0.2 0.2 0.3 1.6 0.7 984.9 0.2 0.1 0.2 2.3 0.2 2.3 0.0 0.6 0.2 0.2 2.0 23.9 0.3 0.2 0.2 0.8 0.3 0.0 0.0 0.2 6.6 3.5 0.2 1.3 0.0 0.1 39.0 0.4 0.1 0.3 0.1 1.7 2.0 0.1 0.0 0.0 0.9 0.0 4.8 1.1 0.5 0.2 4.7 0.4 0.0 0.0 2.1 2.1 0.0 4.4 1.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 15.9 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.2 0.0 12.3 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 39.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 1.5 2.8 4.2 1.2 0.7 0.3 1.6 2.3 0.0 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261715-96336995 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavourable (1.08e-5)" "prognostic unfavourable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 8.2 7.9 8.0 8.1 14.7 10.2 10.4 10.2 15.0 9.7 8.3 5.1 22.5 10.6 8.4 7.8 9.6 7.0 7.9 20.1 8.6 9.9 9.5 12.8 7.8 21.8 7.1 8.0 9.6 12.1 23.2 4.9 10.8 9.6 5.7 7.4 5.2 8.8 29.8 10.1 10.4 8.3 9.0 6.0 11.8 8.1 5.1 3.6 20.7 11.0 7.7 11.8 9.3 6.8 3.6 6.1 9.4 3.7 5.0 4.6 7.8 10.4 8.1 1.4 3.9 2.9 6.1 2.4 7.6 10.5 7.3 5.1 3.0 3.0 17.2 7.0 7.1 4.3 9.9 7.6 11.4 8.8 7.1 16.9 15.6 1.6 3.0 12.4 5.9 5.1 7.3 10.2 7.2 4.7 8.4 8.9 6.6 3.0 9.6 1.9 2.2 7.6 7.7 7.3 13.0 4.1 8.9 6.1 2.5 2.8 2.5 1.1 5.9 4.2 8.3 6.6 4.1 4.5 8.7 1.8 9.2 8.4 4.1 13.1 5.3 9.4 3.7 2.1 2.8 2.5 4.0 2.6 4.6 3.4 6.1 3.6 4.0 2.9 1.3 5.0 2.4 1.8 2.6 7.8 8.0 14.7 10.2 15.0 8.6 9.9 7.1 8.0 9.6 3.6 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 28 "Daudi: 37.2;MOLT-4: 40.5;U-698: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA047497: " "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 40.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 RAB1A "RAB1, YPT1" ENSG00000138069 "RAB1A, member RAS oncogene family" P62820 2 65070701-65130106 "Plasma proteins, Predicted intracellular proteins" "Autophagy, ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005331, HPA056141" Approved Supported "Endoplasmic reticulum,Cytosol" 19000000 "Endoplasmic reticulum, Cytosol" "CAB005331: AB_632290, HPA056141: " "unprognostic (4.78e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "prognostic unfavourable (4.19e-4)" "unprognostic (1.55e-3)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (4.30e-3)" "unprognostic (2.79e-1)" "unprognostic (4.81e-2)" "unprognostic (2.77e-1)" "unprognostic (7.80e-2)" "unprognostic (1.83e-2)" "unprognostic (8.63e-2)" 53.0 57.6 54.6 34.8 58.4 80.8 54.0 47.7 63.2 49.2 50.3 24.8 53.8 52.7 46.7 75.8 58.8 40.7 40.9 49.9 48.1 52.8 77.8 75.4 48.2 40.7 44.0 55.3 37.1 53.5 38.5 59.7 108.6 47.3 40.5 52.2 34.0 68.7 57.1 43.8 35.5 51.6 47.6 49.6 34.5 53.2 30.9 42.4 21.5 56.9 53.1 34.9 52.2 45.1 19.1 33.2 45.0 37.1 24.4 25.1 22.2 39.2 29.1 35.8 20.8 86.6 51.0 56.4 58.4 39.7 25.9 27.5 50.2 26.0 15.9 33.6 57.6 25.2 32.5 51.9 41.0 19.6 19.5 20.1 23.2 73.6 55.0 20.8 18.3 45.0 53.0 33.9 30.3 50.8 28.6 18.5 50.8 35.1 12.2 25.1 28.2 26.2 12.5 33.9 25.3 50.0 44.0 25.8 23.0 26.8 43.9 49.2 27.3 19.6 48.7 33.4 42.6 35.2 32.6 28.9 17.8 38.3 44.4 32.2 32.3 35.3 37.1 32.2 19.5 36.8 21.5 19.1 21.1 21.0 33.2 13.9 20.5 20.4 45.0 24.4 31.6 27.6 25.1 22.2 54.6 58.4 47.7 63.2 48.1 52.8 44.0 55.3 47.3 42.4 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268533-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" 26000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: " "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favourable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 47.5 47.7 36.2 32.5 42.4 33.1 47.8 35.6 60.6 42.0 45.6 38.0 35.7 46.5 42.0 37.2 61.2 45.8 48.4 50.2 34.5 31.5 47.3 67.8 43.0 51.8 34.8 38.6 44.4 52.9 55.0 42.5 63.6 34.6 49.5 38.4 45.3 62.2 48.6 82.8 50.6 58.0 49.2 38.7 47.3 45.6 36.5 30.9 49.2 54.7 50.4 55.9 40.1 41.2 26.3 36.4 84.7 44.2 36.3 47.3 59.7 39.0 45.4 22.9 31.1 39.3 29.4 21.3 32.5 40.0 44.2 31.2 25.8 41.6 16.3 43.0 47.8 37.9 26.1 46.7 24.3 32.6 23.5 25.9 29.5 22.4 26.2 22.0 47.8 30.7 40.3 37.3 19.4 41.6 26.6 29.8 42.0 78.8 38.1 35.5 24.2 43.1 23.6 18.9 42.6 44.4 37.0 23.0 25.3 24.4 59.9 23.7 91.3 25.5 41.9 42.3 28.6 49.8 28.8 16.3 12.9 21.3 48.0 18.8 38.6 27.2 38.8 61.2 47.3 40.8 35.7 22.7 28.5 38.4 31.6 26.3 25.0 29.7 84.7 36.3 44.2 36.4 30.7 59.7 36.2 42.4 35.6 60.6 34.5 31.5 34.8 38.6 34.6 30.9 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 105.0;vagina: 111.3" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavourable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 49.4 6.1 0.4 26.5 0.5 0.0 54.5 0.3 0.4 18.5 29.9 0.6 10.0 2.1 6.8 24.2 11.5 40.6 8.3 105.0 0.6 0.3 26.8 2.7 13.4 13.3 0.5 0.5 75.5 3.9 0.0 19.7 1.6 2.0 46.2 15.7 19.4 49.0 17.9 10.5 3.3 9.3 20.7 2.4 3.2 6.6 19.0 0.2 1.0 31.5 1.7 5.9 39.6 111.3 1.0 1.2 0.0 0.9 0.2 0.7 0.1 2.4 0.8 0.0 0.1 0.5 1.5 0.0 0.2 0.7 0.1 0.1 0.1 158.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 17.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.2 2.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.4 1.0 0.7 0.3 0.0 0.2 0.9 1.2 0.3 0.1 0.4 0.5 0.3 0.4 0.6 0.3 0.5 0.5 2.0 0.2 RCN3 RLP49 ENSG00000142552 "Reticulocalbin 3" Q96D15 19 49527618-49546962 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.2;ASC TERT1: 36.1;BJ: 57.0;BJ hTERT+ SV40 Large T+ RasG12V: 33.0;fHDF/TERT166: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043134, HPA050402" Uncertain Approved "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" "Endoplasmic reticulum, Vesicles" "HPA043134: , HPA050402: " "unprognostic (7.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.77e-3)" "unprognostic (8.87e-2)" "unprognostic (3.36e-3)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (1.16e-1)" "unprognostic (7.47e-2)" "unprognostic (9.75e-2)" "unprognostic (2.85e-1)" "unprognostic (3.86e-2)" "prognostic unfavourable (5.80e-12)" "unprognostic (5.26e-2)" "unprognostic (3.90e-2)" "unprognostic (1.56e-2)" "unprognostic (4.20e-3)" 19.6 10.9 3.7 18.2 5.3 3.2 15.6 7.2 6.6 36.3 10.7 2.0 9.6 22.2 28.2 33.9 11.4 10.7 26.2 18.2 3.4 3.5 12.6 18.6 12.6 4.4 3.3 2.8 29.5 5.1 2.1 9.0 18.0 6.0 19.4 7.0 10.7 6.2 8.2 10.6 8.2 23.7 16.8 2.9 21.3 7.8 17.3 4.2 1.8 9.9 9.8 7.9 21.5 21.6 0.6 0.5 3.9 0.4 2.3 9.7 1.6 0.5 0.8 0.5 30.3 52.2 36.1 0.3 57.0 14.8 21.5 33.0 0.7 0.2 0.2 3.4 49.8 0.0 1.4 0.1 10.3 0.0 0.4 3.2 0.2 1.6 18.3 0.0 7.5 20.3 0.0 15.0 0.0 8.2 1.4 0.1 17.5 0.6 0.0 0.3 0.2 3.9 0.1 0.7 0.9 0.2 0.0 0.3 1.9 0.0 0.2 0.0 0.2 2.0 19.2 0.3 9.6 24.9 0.0 2.8 8.3 0.5 1.4 1.8 2.4 0.0 0.3 2.2 0.9 0.0 1.0 0.6 2.5 0.9 0.5 0.4 9.7 3.2 3.9 2.3 0.4 0.4 1.9 1.6 3.7 5.3 7.2 6.6 3.4 3.5 3.3 2.8 6.0 4.2 RPL10 "DXS648, DXS648E, FLJ23544, L10, NOV, QM" ENSG00000147403 "Ribosomal protein L10" P27635 X 154389955-154409168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB010339, HPA011311" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" "CAB010339: AB_2181277, HPA011311: AB_1856431" "unprognostic (2.46e-3)" "unprognostic (3.57e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.25e-2)" "unprognostic (2.06e-1)" "unprognostic (6.11e-2)" "unprognostic (9.01e-3)" "unprognostic (1.91e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (3.37e-1)" "prognostic unfavourable (7.67e-6)" "unprognostic (6.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.65e-2)" "unprognostic (5.68e-2)" 103.6 65.3 41.4 108.0 48.5 103.7 152.6 82.4 70.7 118.2 80.6 44.6 107.8 51.3 100.4 75.5 105.2 122.3 52.6 82.5 38.2 31.9 112.1 155.0 97.6 190.2 48.2 37.4 223.5 242.3 35.0 51.9 87.4 53.1 83.6 77.1 66.7 109.9 101.5 125.9 121.8 108.9 78.7 51.4 93.9 90.5 33.9 47.2 158.9 198.9 137.9 134.4 86.9 119.3 252.9 168.6 64.4 124.1 149.1 304.9 445.3 187.8 87.1 87.3 66.8 198.2 375.4 77.2 72.2 167.6 139.1 177.0 77.2 84.5 372.4 175.0 120.5 73.0 170.8 173.0 119.6 81.8 135.4 50.2 62.4 84.6 233.1 107.9 74.4 283.3 274.0 83.6 261.3 218.2 70.7 119.0 135.8 94.3 117.5 105.0 68.7 150.6 140.9 82.7 206.9 151.8 67.1 70.0 117.0 17.4 153.8 213.5 56.0 150.9 105.0 48.7 92.6 109.6 159.9 283.6 204.8 370.4 74.0 155.8 60.8 64.4 124.1 18.1 149.9 107.7 256.2 252.9 251.6 186.2 151.2 243.2 304.9 231.1 13.0 149.1 94.9 168.6 178.0 445.3 41.4 48.5 82.4 70.7 38.2 31.9 48.2 37.4 53.1 47.2 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651821 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 45.5" "Cell line enriched" "Detected in single" 45 "U-2 OS: 29.6" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.6 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.3 0.5 1.0 0.6 0.8 0.2 0.7 0.9 0.9 0.0 0.4 0.2 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RPL14 "CTG-B33, hRL14, L14, RL14" ENSG00000188846 "Ribosomal protein L14" P50914 3 40457292-40468587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 92.6;hTCEpi: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004136 Approved Supported "Endoplasmic reticulum,Cytosol" 210000 "Endoplasmic reticulum, Cytosol" "HPA004136: AB_1079839" "unprognostic (1.36e-3)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (2.54e-1)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (2.11e-1)" "unprognostic (1.54e-1)" "unprognostic (2.90e-2)" "unprognostic (6.14e-3)" "unprognostic (1.15e-1)" 49.9 33.5 28.3 57.4 43.8 47.2 134.4 28.7 57.6 85.4 68.2 21.4 48.0 29.8 87.0 30.9 66.0 61.0 56.7 46.7 40.8 22.8 42.5 69.8 44.6 61.7 24.7 22.2 151.9 117.3 48.4 34.4 60.8 40.6 81.8 42.0 36.2 162.9 73.6 72.3 66.7 39.0 59.1 24.7 69.6 52.4 23.8 11.7 42.9 63.3 100.2 58.5 48.7 77.0 26.6 16.0 4.6 11.6 14.3 38.3 47.9 9.5 5.3 32.5 11.5 26.3 92.6 18.9 14.7 49.3 55.5 42.1 11.1 3.8 41.9 12.4 14.5 2.9 16.5 25.7 32.7 14.2 18.2 20.1 9.2 10.6 40.3 28.5 10.8 44.8 96.7 15.8 33.5 50.8 23.6 5.9 38.4 9.2 9.4 26.0 9.3 17.3 4.4 12.3 20.3 41.1 7.1 10.1 16.3 7.7 7.5 22.3 11.7 15.7 16.9 11.3 8.2 14.3 18.6 18.3 22.0 22.9 5.0 21.5 10.4 3.7 11.6 4.6 21.1 11.6 35.5 26.6 31.7 27.7 16.0 24.1 38.3 34.9 1.8 14.3 9.9 14.6 24.9 47.9 28.3 43.8 28.7 57.6 40.8 22.8 24.7 22.2 40.6 11.7 RPL17 "L17, rpL23" ENSG00000265681 "Ribosomal protein L17" P18621 18 49488453-49492523 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043724, HPA046385" Supported Supported "Endoplasmic reticulum,Cytosol" 28000 "Endoplasmic reticulum, Cytosol" "HPA043724: , HPA046385: " "unprognostic (1.11e-1)" "unprognostic (8.77e-2)" "unprognostic (1.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (3.34e-3)" "prognostic unfavourable (3.60e-5)" "unprognostic (2.69e-1)" "unprognostic (3.29e-3)" "unprognostic (2.11e-1)" "unprognostic (4.35e-3)" "unprognostic (2.72e-2)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (6.54e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-3)" 59.6 60.0 40.5 57.8 58.1 101.1 127.2 41.7 42.9 66.7 64.4 26.3 67.8 40.9 64.1 65.5 84.9 76.7 79.7 49.5 32.2 31.1 99.4 184.2 48.0 106.0 42.9 32.3 177.4 203.2 21.7 72.5 77.1 43.6 60.7 53.1 39.8 83.3 83.8 67.6 76.3 69.7 43.7 38.1 78.5 66.8 92.7 32.9 66.6 81.7 146.2 75.2 58.2 70.4 140.6 102.8 22.2 59.2 95.1 158.9 142.2 98.1 62.5 91.1 107.5 150.7 308.0 86.8 110.5 128.7 104.8 79.5 84.0 47.9 170.4 76.3 109.2 117.9 123.5 198.2 112.3 70.6 127.7 89.9 74.3 114.4 131.4 291.6 72.3 293.3 224.7 109.1 258.9 143.1 87.9 125.1 130.0 79.8 105.2 187.3 92.7 51.4 104.6 118.7 219.3 141.9 117.7 69.8 84.2 40.8 85.1 170.8 80.5 191.1 113.6 77.8 66.2 38.1 115.9 112.9 105.2 157.8 74.4 177.7 74.0 22.2 59.2 15.2 82.8 53.2 158.9 140.6 134.5 109.0 93.7 117.9 150.4 127.9 12.7 95.1 43.8 102.8 104.8 142.2 40.5 58.1 41.7 42.9 32.2 31.1 42.9 32.3 43.6 32.9 RPL17-C18orf32 ENSG00000215472 "RPL17-C18orf32 readthrough" 18 49481681-49492479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043724, HPA046385" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA043724: , HPA046385: " "unprognostic (1.62e-1)" "unprognostic (1.67e-2)" "unprognostic (1.70e-3)" "unprognostic (3.83e-4)" "unprognostic (1.95e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" "unprognostic (2.38e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (5.42e-2)" 7.8 34.4 16.3 17.1 12.5 7.2 8.5 23.6 28.6 9.7 10.7 3.5 11.5 22.8 10.4 9.9 14.8 5.9 13.8 13.7 11.8 14.8 17.6 34.0 8.9 18.9 14.8 4.6 10.5 37.7 3.4 13.7 13.3 6.8 9.6 5.3 6.1 12.6 14.6 11.4 5.6 15.2 5.8 14.1 13.5 10.4 16.3 4.7 11.2 14.2 26.7 12.9 9.1 7.0 6.7 10.6 9.7 9.3 5.8 9.7 10.2 6.6 3.2 13.3 15.7 15.2 9.7 0.3 6.8 5.7 2.6 7.8 2.1 13.7 3.9 3.6 7.2 7.6 10.6 2.2 9.3 8.3 3.5 7.3 2.1 2.8 3.4 7.4 17.2 16.1 5.7 4.1 9.5 3.6 1.5 17.6 15.9 3.2 11.2 5.8 5.9 0.3 6.3 6.1 12.1 22.7 0.7 12.7 23.9 3.1 11.8 15.9 14.8 17.2 1.5 7.6 3.5 8.0 3.8 6.7 8.7 6.5 11.1 4.7 9.7 3.5 9.3 4.9 7.1 6.4 9.2 6.7 9.2 9.4 10.6 6.2 6.3 9.7 9.7 5.8 6.1 7.1 8.4 10.2 16.3 12.5 23.6 11.7 11.8 14.8 14.8 4.6 6.8 4.7 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686782 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" 19000 "Endoplasmic reticulum, Cytosol" "HPA051653: " "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavourable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favourable (8.25e-4)" "unprognostic (5.37e-2)" 61.3 58.9 60.6 99.3 68.8 87.9 135.5 73.0 90.1 94.7 64.0 15.8 84.3 49.6 74.2 98.0 75.5 65.4 82.9 110.0 45.6 43.8 58.3 70.3 122.0 256.0 50.7 46.3 174.7 211.4 25.9 65.5 68.2 53.4 69.0 54.7 30.4 133.9 109.9 175.9 66.2 46.2 98.7 80.7 51.4 60.5 30.2 44.1 61.3 84.7 134.3 71.7 105.1 175.4 128.2 107.7 29.6 65.6 85.5 173.8 214.1 163.5 54.4 83.4 92.0 91.5 164.0 126.3 94.3 105.4 127.5 93.5 108.2 72.5 180.5 117.0 72.1 87.1 96.6 116.8 127.8 96.7 96.9 107.0 47.2 80.9 89.9 120.3 56.7 159.1 149.9 80.2 143.3 107.9 97.9 90.1 117.2 109.3 128.2 184.3 150.1 118.2 113.1 82.3 172.4 130.1 73.0 178.7 83.1 49.1 88.3 209.1 107.9 221.4 78.8 55.6 103.2 30.4 114.6 79.2 101.1 315.6 74.5 127.4 93.2 29.6 65.6 16.3 86.1 57.1 125.2 128.2 136.4 104.2 90.5 127.0 173.8 132.3 10.9 85.5 56.9 107.7 121.1 214.1 60.6 68.8 73.0 90.1 45.6 43.8 50.7 46.3 53.4 44.1 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682411-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 555.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA060776: , HPA063379: " "prognostic favourable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavourable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 65.9 58.8 49.6 116.1 81.5 146.4 149.4 47.8 80.5 69.7 69.9 25.1 64.2 60.1 73.2 74.9 98.4 76.4 88.5 103.5 59.9 33.9 57.0 71.3 111.1 316.9 44.5 49.3 132.2 278.5 10.4 54.6 64.8 64.0 70.1 75.7 42.1 115.8 70.1 124.6 97.9 69.2 109.2 47.1 92.0 72.4 56.8 28.5 74.6 89.3 127.5 120.5 71.0 128.7 341.9 188.5 71.3 122.3 161.9 351.8 555.6 168.0 117.0 74.8 89.7 103.0 197.1 113.1 109.3 138.1 125.4 96.4 147.9 157.1 238.4 86.4 95.6 123.0 98.6 152.4 94.5 87.0 212.0 105.0 114.3 182.4 171.0 190.1 123.6 215.3 272.6 19.7 209.3 124.2 108.0 75.3 105.9 126.6 141.6 286.6 121.5 122.6 124.0 78.6 144.9 117.8 168.5 85.6 153.9 40.5 155.7 169.7 68.8 217.9 112.7 40.8 110.2 105.0 138.0 85.8 187.9 195.0 93.9 130.3 74.1 71.3 122.3 37.8 208.1 119.1 266.8 341.9 295.7 244.4 188.5 301.2 351.8 290.3 29.7 161.9 108.1 180.0 198.2 555.6 49.6 81.5 47.8 80.5 59.9 33.9 44.5 49.3 64.0 28.5 RPL28 "FLJ43307, L28" ENSG00000108107 "Ribosomal protein L28" P46779 19 55385345-55403250 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050459 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA050459: " "unprognostic (4.70e-3)" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (6.53e-2)" "unprognostic (9.73e-2)" "unprognostic (3.38e-2)" "unprognostic (2.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.93e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-1)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.61e-5)" "unprognostic (4.28e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-1)" "unprognostic (8.93e-3)" 91.7 86.3 81.9 112.8 68.3 166.7 88.9 32.8 84.1 117.1 107.7 86.7 71.1 89.9 144.6 81.3 224.2 105.0 118.0 72.9 66.2 54.4 87.1 228.8 133.0 398.1 70.4 50.7 200.5 198.5 25.5 73.7 88.7 53.2 122.7 61.2 88.0 143.3 77.9 102.1 136.4 108.1 76.8 70.7 205.5 85.8 75.9 27.4 375.5 144.6 108.5 269.6 131.8 121.7 139.5 93.6 27.8 77.2 66.7 146.6 190.9 119.3 139.0 48.4 96.1 86.5 139.3 81.7 81.1 77.6 71.0 65.9 135.4 63.8 179.5 58.4 73.4 75.2 55.0 104.2 31.5 69.4 312.4 110.7 87.9 164.7 143.9 128.7 97.6 195.4 149.9 52.7 106.9 76.2 85.6 147.8 63.2 138.0 143.8 119.7 115.9 152.1 146.0 69.8 136.6 89.9 239.2 61.7 102.0 51.6 170.2 122.1 70.7 138.0 92.3 63.5 71.6 50.8 128.5 121.9 175.6 112.0 81.1 157.6 53.5 27.8 77.2 21.9 77.0 67.8 119.7 137.8 129.9 101.2 93.6 139.5 146.6 130.8 24.4 66.7 56.3 88.3 117.7 190.9 81.9 68.3 32.8 84.1 66.2 54.4 70.4 50.7 53.2 27.4 RPL30 L30 ENSG00000156482 "Ribosomal protein L30" P62888 8 98024851-98046469 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002651 Approved Approved "Endoplasmic reticulum,Cytosol" 52000 "Endoplasmic reticulum, Cytosol" "HPA002651: AB_1079842" "unprognostic (3.28e-2)" "unprognostic (2.19e-1)" "unprognostic (7.36e-2)" "unprognostic (2.42e-2)" "unprognostic (3.48e-3)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (3.34e-1)" "unprognostic (2.89e-1)" "unprognostic (2.49e-2)" "unprognostic (4.76e-2)" "prognostic unfavourable (1.41e-9)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (5.97e-3)" 146.2 68.8 77.6 75.4 56.2 153.1 195.1 54.3 62.0 158.8 123.2 64.1 96.3 57.5 146.1 120.3 164.9 126.6 113.5 147.3 64.5 53.1 75.7 140.6 121.2 383.2 78.6 46.4 284.8 344.3 44.6 62.1 97.5 49.3 154.7 96.3 66.2 172.7 131.4 191.2 144.8 90.1 164.3 85.2 146.6 96.3 79.5 58.7 168.1 170.4 102.5 176.5 153.6 197.4 180.4 94.5 42.1 70.0 94.2 238.2 179.6 146.7 100.8 108.6 104.1 156.6 290.4 104.6 86.7 151.6 146.4 128.6 111.2 138.8 192.1 227.0 123.7 96.3 135.2 161.0 152.5 75.8 112.9 167.3 100.9 145.7 230.5 89.1 83.7 246.3 255.8 108.4 311.0 150.2 119.4 127.5 124.2 195.2 207.8 167.2 97.1 146.4 112.6 82.7 176.7 119.4 136.4 157.0 134.5 50.2 125.5 197.9 165.2 212.1 83.4 57.3 61.7 85.5 103.7 134.5 108.9 157.3 80.5 182.3 83.7 42.1 70.0 31.6 104.4 63.1 154.1 180.4 181.2 138.9 94.5 171.7 238.2 186.0 26.3 94.2 55.6 94.0 117.8 179.6 77.6 56.2 54.3 62.0 64.5 53.1 78.6 46.4 49.3 58.7 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841588 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 406.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" 140000 "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 80.5 42.2 62.9 55.4 44.5 106.7 109.0 33.2 50.8 101.5 58.9 34.9 38.3 37.3 63.1 91.5 94.8 82.3 49.5 53.5 46.5 36.5 68.4 132.9 63.7 117.4 50.1 41.1 167.0 406.2 20.4 38.6 48.6 32.8 62.6 68.4 41.8 67.9 43.3 121.4 90.5 48.6 78.0 48.4 77.7 52.0 55.9 30.7 103.9 66.9 87.7 121.5 91.2 68.9 230.3 119.2 38.8 86.1 104.4 281.7 293.2 73.3 88.3 77.1 98.2 121.3 217.4 254.8 60.7 113.1 128.3 88.0 116.6 75.3 128.1 55.5 87.1 46.1 87.4 126.1 105.6 59.1 146.3 74.4 112.0 126.0 181.4 119.9 75.6 195.0 275.4 97.8 189.2 111.9 91.3 119.1 104.7 221.5 134.7 207.3 129.9 167.7 107.7 69.3 166.7 129.6 122.3 49.0 98.0 40.8 109.8 130.4 160.7 231.2 64.5 55.7 71.2 73.1 111.3 80.6 126.5 223.9 70.9 172.2 82.9 38.8 86.1 22.9 99.1 66.7 178.3 230.3 197.2 143.1 119.2 214.7 281.7 213.1 12.7 104.4 53.6 118.2 147.0 293.2 62.9 44.5 33.2 50.8 46.5 36.5 50.1 41.1 32.8 30.7 RPL35 L35 ENSG00000136942 "Ribosomal protein L35" P42766 9 124857880-124861981 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA006047 Approved Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA006047: AB_1856443" "unprognostic (1.16e-2)" "unprognostic (5.42e-3)" "unprognostic (3.04e-2)" "unprognostic (3.69e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" "unprognostic (2.67e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-3)" "unprognostic (6.58e-2)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" 91.6 70.1 81.9 116.6 59.2 178.1 156.1 49.2 55.6 109.3 118.5 45.8 86.8 63.0 95.1 98.9 158.5 98.4 89.9 97.0 60.2 55.0 77.5 140.3 89.1 228.4 65.9 48.1 189.1 492.3 25.7 67.0 71.8 45.8 118.3 56.6 63.9 150.9 98.5 247.1 142.7 75.6 131.5 60.8 113.4 78.2 60.5 46.0 113.3 128.4 154.6 130.1 125.5 176.4 201.4 172.2 31.1 82.2 105.1 165.8 281.7 93.3 145.8 82.8 113.5 90.5 192.0 113.6 73.7 119.1 153.8 105.0 240.5 92.6 140.1 76.7 82.0 181.0 96.0 161.3 56.5 85.7 166.0 56.6 198.0 155.3 161.6 125.8 75.7 176.7 252.5 90.9 161.8 112.8 121.3 177.8 115.2 303.3 148.1 288.7 155.1 179.8 126.5 127.7 311.6 131.9 110.8 112.1 91.0 66.9 158.7 149.3 161.3 207.8 57.8 68.6 72.6 119.0 149.5 100.3 233.6 208.8 96.4 132.6 115.2 28.5 82.2 31.1 116.6 72.1 155.1 201.4 156.5 133.8 121.0 189.4 165.8 143.9 10.8 105.1 58.8 172.2 122.6 281.7 81.9 59.2 49.2 55.6 60.2 55.0 65.9 48.1 45.8 46.0 RPL36 "DKFZp566B023, L36" ENSG00000130255 "Ribosomal protein L36" Q9Y3U8 19 5674947-5691876 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047153 Supported Uncertain "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA047153: " "unprognostic (2.81e-2)" "unprognostic (5.70e-3)" "unprognostic (8.16e-2)" "unprognostic (6.28e-3)" "unprognostic (2.25e-2)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (5.48e-2)" "unprognostic (1.29e-1)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (4.65e-2)" "prognostic unfavourable (2.32e-4)" "unprognostic (7.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.23e-2)" "unprognostic (3.51e-2)" 52.2 101.2 56.3 80.9 43.1 120.2 88.4 40.8 71.1 59.7 63.4 21.2 58.0 60.4 72.2 64.9 79.6 63.2 66.2 69.6 39.7 33.9 48.4 59.7 58.6 201.6 38.7 52.9 225.0 196.1 12.9 48.0 38.6 34.9 65.0 36.7 29.4 129.4 70.4 78.7 101.9 61.4 60.8 39.5 75.3 64.7 53.8 32.3 39.9 40.9 106.1 55.5 48.4 103.1 163.2 79.0 29.1 57.6 68.6 180.7 220.0 100.2 50.3 35.3 87.3 42.2 81.6 52.3 55.3 36.2 56.4 46.5 93.3 51.2 68.5 134.1 26.1 70.8 31.7 65.8 17.1 51.8 223.2 43.1 51.7 76.8 93.6 92.8 60.6 69.5 108.2 34.9 73.4 47.5 55.2 223.1 32.8 107.1 115.1 128.8 118.7 171.3 71.6 41.5 185.9 54.3 67.2 62.9 84.3 32.6 93.6 154.5 72.2 159.9 50.8 37.2 49.9 54.3 120.6 110.1 100.0 107.3 70.7 149.0 51.8 29.1 57.6 21.4 77.3 48.3 125.2 161.4 157.2 113.1 79.0 163.2 180.7 146.6 8.0 68.6 40.4 74.6 120.6 220.0 56.3 43.1 40.8 71.1 39.7 33.9 38.7 52.9 34.9 32.3 RPL37A L37A ENSG00000197756 "Ribosomal protein L37a" P61513 2 216498189-216579180 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065327 Approved Approved "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA065327: " "unprognostic (9.94e-3)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.19e-1)" "unprognostic (5.12e-3)" "unprognostic (6.92e-2)" "unprognostic (1.76e-2)" "unprognostic (2.67e-1)" "unprognostic (8.26e-2)" "unprognostic (2.33e-1)" "unprognostic (2.62e-1)" "unprognostic (8.84e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (1.49e-1)" "unprognostic (4.92e-2)" "unprognostic (1.05e-2)" "unprognostic (1.67e-1)" 115.0 109.4 130.0 114.9 104.2 153.1 252.9 78.4 82.8 134.5 129.9 66.0 80.5 79.8 188.5 123.9 154.9 131.5 90.7 154.0 91.2 81.7 81.0 116.7 100.7 283.5 108.6 91.0 281.8 423.2 47.3 84.3 74.1 89.0 134.7 115.2 77.9 265.7 107.8 307.2 159.0 76.6 171.8 98.6 97.6 99.0 130.3 60.1 117.2 123.7 186.1 154.7 137.2 195.1 215.6 197.7 39.6 103.3 119.1 222.5 229.2 82.4 70.6 153.4 103.2 160.5 282.9 114.0 112.5 151.2 114.8 98.3 178.9 80.5 91.2 158.0 138.0 86.7 144.9 165.8 118.9 103.7 153.6 149.0 128.0 252.5 274.9 163.5 93.9 306.4 349.5 99.3 280.6 158.2 116.0 134.0 148.5 166.4 155.0 336.8 177.5 80.7 112.6 115.3 111.0 159.9 145.4 99.6 112.1 41.5 130.2 256.2 82.3 283.2 106.0 83.1 90.8 81.4 122.8 142.5 200.7 174.0 92.7 114.6 84.0 39.6 103.3 24.2 122.9 77.1 168.0 215.2 190.4 151.9 143.0 215.6 222.5 198.2 13.5 119.1 63.9 197.7 136.5 229.2 130.0 104.2 78.4 82.8 91.2 81.7 108.6 91.0 89.0 60.1 RPL38 L38 ENSG00000172809 "Ribosomal protein L38" P63173 17 74203582-74210655 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052543 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA052543: " "unprognostic (1.68e-3)" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.99e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (7.71e-3)" "unprognostic (4.95e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (6.17e-8)" "unprognostic (1.89e-1)" "unprognostic (6.00e-2)" "unprognostic (1.18e-1)" "unprognostic (3.39e-2)" 105.7 85.6 114.6 92.9 94.2 140.7 148.5 58.8 142.3 91.1 107.6 42.6 88.1 74.9 88.2 104.6 89.3 88.2 86.2 152.3 87.3 69.2 67.5 83.5 132.5 313.8 111.4 104.1 258.2 305.8 26.7 59.9 62.8 95.4 73.0 79.4 41.2 118.9 101.8 283.6 108.0 73.8 150.8 162.9 108.0 77.7 99.6 108.3 77.1 67.7 143.5 133.2 92.9 195.6 174.9 141.2 54.0 106.3 80.4 217.6 213.6 95.1 94.6 91.2 93.0 125.0 148.2 90.4 103.7 67.0 95.0 66.6 106.1 73.1 168.5 72.7 88.6 86.1 108.7 134.6 74.5 46.9 174.4 96.3 80.3 136.9 146.0 179.7 86.1 284.4 189.4 89.1 145.3 138.8 118.1 94.0 79.3 100.2 174.0 217.4 106.6 143.4 126.0 193.5 149.6 112.5 74.7 82.7 154.3 43.3 181.3 224.3 138.1 187.3 90.7 79.5 129.5 73.1 135.3 127.8 197.0 173.9 65.1 119.2 75.5 54.0 106.3 37.3 112.2 84.4 132.9 174.9 190.5 140.5 115.2 174.7 217.6 185.8 34.0 80.4 74.5 141.2 117.4 213.6 114.6 94.2 58.8 142.3 87.3 69.2 111.4 104.1 95.4 108.3 RPLP0 "L10E, LP0, P0, PRLP0, RPP0" ENSG00000089157 "Ribosomal protein lateral stalk subunit P0" P05388 12 120196686-120201235 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 408.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003512, HPA073501" Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA003512: AB_1079844, HPA073501: " "unprognostic (2.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (8.49e-3)" "unprognostic (2.99e-2)" "unprognostic (2.44e-1)" "unprognostic (2.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.67e-1)" "unprognostic (4.82e-2)" "unprognostic (2.34e-1)" "unprognostic (3.35e-1)" "prognostic unfavourable (7.66e-12)" "unprognostic (2.74e-1)" "unprognostic (2.39e-1)" "unprognostic (3.06e-1)" "unprognostic (1.47e-1)" 67.3 59.5 20.6 76.6 31.6 100.5 119.8 26.8 26.0 58.4 76.8 22.0 61.8 50.5 95.9 66.0 128.3 74.8 88.6 49.8 28.9 16.2 47.1 121.7 55.4 59.7 21.9 26.6 117.5 408.6 13.5 36.6 70.1 41.5 72.4 60.8 32.8 138.5 54.6 101.0 113.9 57.3 63.8 23.4 60.0 69.0 73.0 18.7 89.6 90.8 162.5 82.8 64.2 116.6 135.9 143.3 10.7 63.4 82.7 172.4 193.3 126.0 109.1 92.8 158.8 189.6 312.3 132.4 97.1 168.7 152.0 99.1 120.6 77.6 276.3 98.2 169.9 100.2 164.3 201.7 96.3 106.7 125.2 131.8 72.4 103.0 204.5 177.0 99.7 281.5 345.4 106.5 316.4 179.5 161.4 80.1 144.5 136.4 178.2 119.7 176.8 146.2 130.0 130.6 216.4 152.0 145.6 99.1 120.7 70.0 104.8 190.8 187.1 214.1 120.6 71.7 109.4 90.8 120.4 181.1 190.6 137.9 128.8 127.4 60.3 10.7 63.4 5.3 71.5 58.3 172.4 135.9 131.9 97.1 137.0 123.2 131.4 104.4 5.0 82.7 35.1 143.3 83.4 193.3 20.6 31.6 26.8 26.0 28.9 16.2 21.9 26.6 41.5 18.7 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452784-69456194 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 1030.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" 1000000 "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavourable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 59.6 57.2 47.5 76.8 42.9 171.7 451.2 68.8 103.3 70.1 79.0 20.8 57.9 87.5 73.5 76.3 100.7 65.7 80.6 341.6 35.5 29.7 55.8 69.9 290.9 1030.2 42.4 33.3 134.3 209.0 8.6 36.0 52.3 45.6 71.0 33.3 61.3 102.8 60.7 262.9 155.2 74.3 128.2 38.8 77.4 77.1 45.7 32.7 73.0 50.8 146.9 71.8 72.3 95.5 329.0 226.3 79.6 176.1 169.8 267.2 368.8 82.7 84.7 38.0 87.6 54.5 65.8 81.7 72.9 43.3 40.8 32.7 85.9 84.4 115.9 109.0 38.3 113.3 58.5 57.3 8.9 116.2 179.0 97.6 97.3 83.8 95.5 86.4 89.2 82.7 100.5 29.7 55.7 49.2 91.8 98.9 28.8 77.6 94.2 254.8 142.1 81.7 96.7 124.2 169.6 39.3 89.7 60.9 118.7 73.2 90.6 297.4 74.7 199.0 86.3 59.2 132.5 70.6 118.3 202.7 323.2 98.3 70.9 220.7 48.8 79.6 176.1 60.4 119.5 124.7 220.2 329.0 247.2 162.7 215.0 278.5 267.2 223.0 26.2 169.8 70.2 226.3 202.7 368.8 47.5 42.9 68.8 103.3 35.5 29.7 42.4 33.3 45.6 32.7 RPS14 "EMTB, S14" ENSG00000164587 "Ribosomal protein S14" P62263 5 150442635-150449756 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 708.0;pancreas: 483.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018504 Approved Supported "Endoplasmic reticulum,Cytosol" 540000 "Endoplasmic reticulum, Cytosol" "HPA018504: AB_1856463" "unprognostic (5.70e-3)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (8.17e-3)" "unprognostic (7.51e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (3.26e-1)" "prognostic unfavourable (8.69e-4)" "unprognostic (1.47e-1)" "unprognostic (8.81e-2)" "unprognostic (2.29e-1)" "unprognostic (8.14e-2)" 60.9 43.2 50.1 64.3 39.1 92.8 111.6 22.6 37.2 85.1 70.3 28.0 50.6 33.6 59.6 86.4 79.4 91.7 57.2 59.2 35.7 30.3 53.6 74.7 57.0 96.6 39.8 32.5 115.1 483.0 17.4 38.9 62.0 35.3 69.7 61.5 41.1 61.8 50.8 93.4 95.0 60.6 67.0 37.0 68.4 58.3 48.5 33.8 84.5 93.9 71.2 83.6 87.1 65.2 360.5 205.3 51.0 166.0 157.4 465.9 708.0 87.6 160.8 83.7 170.4 128.2 241.2 137.4 67.4 113.0 110.0 100.4 219.1 113.1 199.0 99.3 127.2 70.3 125.2 299.6 74.8 92.3 151.2 72.3 149.2 164.5 182.4 206.4 74.9 183.1 117.3 112.0 264.2 152.8 95.4 78.8 139.2 236.7 89.1 174.1 86.2 136.6 87.5 96.4 213.1 143.9 161.3 92.3 105.1 48.8 244.4 193.4 107.7 226.5 94.7 59.5 50.0 50.3 90.6 107.0 150.4 130.7 74.2 202.4 39.2 51.0 166.0 36.7 186.2 114.2 261.9 360.5 313.3 226.8 181.1 299.4 465.9 319.4 25.7 157.4 97.0 205.3 196.8 708.0 50.1 39.1 22.6 37.2 35.7 30.3 39.8 32.5 35.3 33.8 RPS15 "MGC111130, RIG, S15" ENSG00000115268 "Ribosomal protein S15" P62841 19 1438358-1440494 "Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054510, HPA057793" Enhanced Approved "Endoplasmic reticulum,Cytosol" 170000 "Endoplasmic reticulum, Cytosol" "HPA054510: AB_2682510, HPA057793: AB_2683528" "unprognostic (4.47e-3)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.08e-3)" "unprognostic (5.98e-2)" "unprognostic (2.05e-1)" "unprognostic (4.33e-3)" "unprognostic (4.42e-2)" "unprognostic (2.58e-1)" "unprognostic (2.73e-2)" "unprognostic (3.28e-2)" "unprognostic (5.00e-2)" "unprognostic (1.44e-3)" "unprognostic (5.21e-2)" "unprognostic (5.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.61e-2)" 61.7 61.2 63.0 67.5 51.4 123.6 74.2 46.0 87.5 56.2 66.4 46.1 41.2 69.0 73.6 52.3 80.9 61.2 73.7 72.1 50.4 40.5 64.8 103.7 43.0 95.3 52.1 52.6 144.8 136.0 21.6 59.3 60.9 45.2 66.9 37.1 61.2 123.7 53.2 154.9 102.4 67.6 51.8 51.0 76.2 63.5 60.8 24.9 70.7 74.2 127.6 82.9 47.6 70.9 237.3 149.5 48.6 106.7 103.8 218.1 269.2 103.1 110.2 48.5 65.9 45.5 66.3 83.6 54.1 43.2 64.9 50.9 176.9 36.5 128.1 48.7 34.7 65.8 47.2 67.0 25.5 106.5 246.9 41.9 101.0 167.0 48.2 106.6 80.0 81.4 81.0 43.9 43.1 57.1 85.0 184.5 40.5 181.6 88.0 143.3 109.7 141.8 91.7 57.9 167.3 58.9 113.7 78.1 92.7 45.6 78.7 155.1 60.2 143.7 57.6 55.0 63.0 109.6 119.3 160.3 158.6 124.5 54.6 97.4 62.8 48.6 106.7 44.5 116.2 89.5 160.8 237.3 179.3 146.1 149.5 222.5 218.1 177.4 21.6 103.8 68.2 124.2 162.9 269.2 63.0 51.4 46.0 87.5 50.4 40.5 52.1 52.6 45.2 24.9 RPS16 S16 ENSG00000105193 "Ribosomal protein S16" P62249 19 39433207-39435948 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064222 Approved Supported "Endoplasmic reticulum,Cytosol" 36000 "Endoplasmic reticulum, Cytosol" "HPA064222: " "unprognostic (4.63e-3)" "unprognostic (4.78e-2)" "unprognostic (2.73e-1)" "unprognostic (9.49e-2)" "unprognostic (2.20e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.96e-1)" "unprognostic (1.89e-3)" "unprognostic (4.40e-2)" "unprognostic (5.28e-2)" "unprognostic (5.73e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-2)" "unprognostic (2.06e-1)" "unprognostic (4.62e-2)" 89.8 60.8 49.0 123.2 46.1 127.3 126.9 39.8 46.8 124.8 120.7 48.6 80.0 67.2 97.9 80.8 150.1 108.1 105.9 118.7 41.7 35.7 81.5 147.6 103.7 243.2 49.2 29.9 248.1 457.6 19.9 48.8 97.0 35.5 129.5 52.8 73.8 130.5 87.6 205.5 113.4 110.9 126.3 52.2 136.7 92.1 57.4 37.7 153.9 125.1 183.6 151.0 143.8 159.8 153.7 106.4 17.6 71.8 71.7 179.1 225.5 138.3 296.6 79.7 90.4 120.1 148.1 74.0 63.8 74.7 83.4 76.9 188.7 76.9 117.3 82.9 79.6 46.3 93.2 155.3 52.8 137.0 220.6 92.6 101.0 194.9 122.6 135.1 62.9 172.7 242.1 73.5 117.4 106.9 118.2 132.7 86.9 213.9 184.6 136.3 98.4 108.6 123.8 82.4 141.9 91.5 156.3 81.1 116.8 47.9 215.8 164.1 61.9 262.6 64.2 69.6 91.3 73.7 138.8 185.0 191.5 148.7 72.0 129.3 67.1 17.6 71.8 11.0 84.5 57.9 120.9 153.7 140.8 105.6 91.9 143.2 179.1 143.0 13.2 71.7 48.2 106.4 94.7 225.5 49.0 46.1 39.8 46.8 41.7 35.7 49.2 29.9 35.5 37.7 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962052-1964860 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 284.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" 140000 "Endoplasmic reticulum, Cytosol" "HPA055133: " "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavourable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavourable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 46.1 41.0 28.0 101.8 40.4 97.6 65.9 34.7 30.7 48.2 47.0 22.2 28.8 39.9 45.7 27.1 100.7 61.7 55.7 38.2 19.5 16.0 34.2 107.4 71.1 104.2 36.6 18.6 112.6 284.3 9.6 32.2 45.4 30.1 43.6 32.5 18.3 53.6 28.9 67.3 78.3 47.5 25.8 22.4 131.9 47.8 18.9 28.1 115.2 50.3 114.5 78.3 51.6 77.6 137.5 69.0 18.2 44.9 53.6 125.4 54.7 81.0 117.7 68.2 219.3 99.1 244.6 120.8 55.7 133.9 146.3 103.9 209.6 56.8 155.5 89.2 96.2 101.9 98.5 186.8 55.0 98.1 194.8 52.4 131.3 187.7 242.1 123.0 86.5 326.4 267.9 122.2 203.4 141.8 107.1 88.4 100.8 376.2 154.3 215.6 216.7 106.4 189.2 110.5 185.9 133.5 77.2 122.3 111.1 54.5 171.3 132.0 115.5 216.0 64.7 78.9 104.0 18.9 116.4 34.4 56.6 197.9 42.5 106.6 99.0 4.9 37.6 18.2 50.7 44.9 84.6 137.5 99.9 78.4 68.7 117.9 125.4 93.8 7.6 53.6 36.0 69.0 68.1 54.7 28.0 40.4 34.7 30.7 19.5 16.0 36.6 18.6 30.1 28.1 RPS20 S20 ENSG00000008988 "Ribosomal protein S20" P60866 8 56067295-56074581 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003570 Approved Supported "Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" "HPA003570: AB_1856466" "unprognostic (2.57e-2)" "unprognostic (6.91e-2)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.99e-1)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (6.75e-2)" "unprognostic (9.78e-2)" "unprognostic (4.83e-2)" "unprognostic (3.46e-1)" "prognostic unfavourable (1.21e-8)" "unprognostic (3.64e-2)" "unprognostic (8.80e-3)" "unprognostic (2.33e-3)" "unprognostic (2.19e-2)" 164.6 74.7 74.1 177.3 61.8 191.2 193.8 30.4 57.8 148.1 118.9 49.5 104.1 58.3 100.6 108.4 161.3 91.2 108.3 140.0 57.3 47.0 88.0 136.5 124.0 280.9 67.7 41.8 267.4 218.0 28.5 69.2 77.9 48.1 136.7 60.5 70.2 165.9 104.1 161.5 132.2 86.1 152.5 75.9 157.1 98.5 79.6 47.5 168.0 141.7 143.6 140.8 179.7 157.7 214.3 142.6 64.0 77.1 78.0 248.9 267.6 142.9 128.2 126.5 122.9 181.6 209.9 107.4 96.4 143.2 114.7 105.5 132.8 139.0 211.1 119.3 101.4 90.4 78.8 152.1 97.1 91.3 109.5 175.0 118.1 165.6 174.5 97.6 115.2 205.0 159.3 75.0 216.9 138.8 139.9 126.5 112.9 176.5 266.9 195.4 169.6 55.4 146.7 46.6 109.0 137.7 155.4 42.3 131.5 41.6 113.3 188.5 164.3 203.1 90.8 86.7 149.1 114.2 152.2 138.0 118.7 154.1 131.6 171.2 77.2 64.0 77.1 31.3 101.6 64.5 144.7 214.3 189.1 135.6 100.5 180.9 248.9 181.3 14.6 78.0 59.0 142.6 125.7 267.6 74.1 61.8 30.4 57.8 57.3 47.0 67.7 41.8 48.1 47.5 RPS21 S21 ENSG00000171858 "Ribosomal protein S21" P63220 20 62387116-62388520 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003371 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA003371: AB_1079846" "unprognostic (1.92e-2)" "unprognostic (1.41e-1)" "unprognostic (1.31e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (8.46e-4)" "unprognostic (6.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "unprognostic (4.60e-1)" 69.0 66.0 93.6 140.3 61.5 191.6 177.7 59.2 89.7 93.5 105.1 24.3 84.0 72.0 121.5 85.7 99.6 93.3 97.8 66.0 65.6 47.3 62.9 86.1 66.4 199.9 74.0 86.6 189.4 321.2 12.8 49.2 53.0 52.7 76.3 61.9 33.1 164.2 97.3 172.3 129.6 71.5 120.0 51.1 94.9 73.3 92.9 60.0 92.9 86.3 175.2 90.8 84.4 229.7 170.4 122.5 18.1 59.8 71.0 175.9 158.2 99.5 104.1 53.1 100.4 59.2 105.1 70.1 64.4 51.6 161.6 61.6 347.1 133.6 122.4 133.4 49.6 139.9 58.8 179.3 55.8 30.4 153.0 201.5 149.2 263.9 120.8 154.8 90.9 116.8 251.0 61.1 111.3 74.9 102.9 102.0 55.3 151.5 173.8 220.5 81.3 318.5 118.0 135.0 185.0 75.8 112.7 97.8 96.9 66.2 296.6 134.7 126.1 203.4 78.7 95.6 126.4 80.9 125.9 163.2 185.3 133.2 114.3 94.6 50.6 18.1 59.8 13.9 85.7 50.5 122.2 170.4 146.0 112.6 87.6 170.0 175.9 152.7 9.4 71.0 40.0 122.5 92.7 158.2 93.6 61.5 59.2 89.7 65.6 47.3 74.0 86.6 52.7 60.0 RPS23 S23 ENSG00000186468 "Ribosomal protein S23" P62266 5 82273358-82278577 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" "HPA054853: " "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 114.6 62.1 72.6 129.7 54.8 139.2 191.8 45.1 53.7 141.2 118.9 46.5 83.5 62.2 131.8 94.1 145.2 118.3 114.4 79.4 61.4 52.9 92.8 134.8 90.1 200.7 74.4 34.7 269.5 211.6 41.6 65.6 94.6 51.9 134.3 89.8 52.9 126.7 84.7 205.4 134.3 97.0 129.6 77.7 150.1 83.8 61.4 51.5 194.5 141.5 171.9 173.8 160.7 165.8 140.7 110.8 11.1 56.6 63.8 136.1 158.2 91.4 36.1 104.0 79.7 175.1 236.9 106.1 87.9 133.4 133.1 132.4 50.6 62.6 215.9 61.7 113.8 47.2 155.5 252.9 138.3 78.3 87.8 88.3 53.4 49.1 231.4 127.4 64.1 227.3 301.0 101.5 266.8 171.4 91.7 68.0 114.9 59.5 140.4 129.4 66.5 84.1 94.1 149.1 194.0 129.2 38.7 66.9 87.5 45.3 78.9 178.1 59.9 197.7 121.6 19.0 73.9 46.2 138.0 97.9 143.0 151.7 44.8 165.1 41.6 11.1 56.6 8.7 60.1 52.4 92.2 140.7 103.0 81.1 97.6 130.8 136.1 112.3 6.0 63.8 43.3 110.8 73.4 158.2 72.6 54.8 45.1 53.7 61.4 52.9 74.4 34.7 51.9 51.5 RPS25 S25 ENSG00000118181 "Ribosomal protein S25" P62851 11 119015712-119018691 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031801 Approved Approved "Endoplasmic reticulum,Cytosol" 54000 "Endoplasmic reticulum, Cytosol" "HPA031801: AB_10610419" "unprognostic (1.60e-2)" "unprognostic (1.79e-1)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "unprognostic (8.32e-2)" "unprognostic (1.78e-2)" "unprognostic (1.55e-2)" "unprognostic (8.47e-2)" "unprognostic (5.23e-2)" "unprognostic (1.54e-2)" "unprognostic (2.36e-2)" "unprognostic (7.75e-3)" "prognostic unfavourable (3.00e-7)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (8.58e-2)" "unprognostic (2.20e-1)" 72.3 68.1 54.9 99.5 60.7 117.7 140.7 38.1 62.2 84.9 69.4 26.8 87.7 53.5 79.6 93.4 92.9 68.0 78.6 87.3 44.4 41.7 58.6 76.5 88.4 256.5 57.1 48.1 190.0 274.5 34.3 67.5 52.5 54.3 77.1 52.2 41.6 113.5 131.7 173.6 82.0 57.7 125.4 68.3 80.7 68.3 35.3 47.3 78.5 83.9 128.8 86.4 112.2 110.6 136.6 83.3 30.0 43.2 64.7 166.9 150.1 38.9 22.4 48.3 48.3 65.1 100.7 39.7 52.8 47.6 31.2 27.2 59.3 68.5 98.7 92.3 36.7 54.2 42.7 56.8 35.5 48.5 46.6 140.6 19.8 49.8 50.5 99.8 43.9 90.6 101.3 29.8 74.4 56.6 73.0 59.6 43.3 80.3 78.0 137.1 49.8 54.3 68.4 50.7 107.2 57.5 34.3 35.5 67.5 28.1 87.5 54.6 70.3 108.9 53.8 30.6 35.6 30.9 50.6 50.5 41.2 81.5 21.2 99.3 36.1 30.0 43.2 27.1 75.8 42.5 120.7 136.6 133.4 102.4 69.1 112.6 166.9 128.2 11.7 64.7 37.2 83.3 88.7 150.1 54.9 60.7 38.1 62.2 44.4 41.7 57.1 48.1 54.3 47.3 RPS29 S29 ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 526.9;pancreas: 892.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004107 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favourable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 59.9 53.6 54.5 108.8 58.9 140.0 155.5 34.4 88.2 68.6 89.6 17.9 67.6 71.4 54.9 67.9 75.3 56.1 63.5 108.2 43.1 33.8 54.5 75.3 74.3 232.1 64.3 56.2 128.3 892.4 8.5 41.6 44.5 53.1 50.6 58.9 29.2 86.0 67.9 177.4 102.6 70.9 76.3 74.6 98.1 63.3 94.0 60.6 53.2 45.6 136.9 101.6 47.1 83.8 303.1 164.3 62.9 102.0 123.1 363.7 526.9 147.8 98.1 102.7 91.9 118.1 201.4 135.9 101.5 86.7 92.8 76.1 98.9 137.2 135.0 116.3 85.2 129.7 117.9 144.4 103.3 88.0 213.0 105.7 89.0 172.2 144.7 269.6 91.9 208.2 236.5 60.9 177.8 132.0 117.8 177.5 89.8 196.7 184.0 168.0 125.2 277.2 154.7 127.9 154.5 111.8 132.6 77.8 89.8 72.0 133.3 235.1 173.8 235.9 121.7 71.1 190.8 66.0 89.6 205.0 227.5 182.7 50.1 111.4 68.4 62.9 102.0 46.1 175.8 81.1 219.7 303.1 322.1 227.3 122.6 281.3 363.7 295.6 24.4 123.1 73.4 164.3 181.8 526.9 54.5 58.9 34.4 88.2 43.1 33.8 64.3 56.2 53.1 60.6 RPS3 "FLJ26283, FLJ27450, MGC87870, S3" ENSG00000149273 "Ribosomal protein S3" P23396 11 75399486-75422280 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063339 Uncertain Supported "Endoplasmic reticulum,Cytosol" 430000 "Endoplasmic reticulum, Cytosol" "HPA063339: " "unprognostic (3.62e-2)" "unprognostic (6.94e-3)" "unprognostic (2.64e-1)" "unprognostic (1.44e-2)" "unprognostic (5.55e-2)" "unprognostic (1.08e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-2)" "unprognostic (3.27e-3)" "unprognostic (1.96e-1)" "prognostic unfavourable (6.92e-6)" "unprognostic (3.22e-1)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (2.19e-1)" 72.2 52.7 36.6 108.4 41.2 122.2 136.6 32.1 33.8 105.1 102.0 32.5 65.2 65.8 102.4 84.7 136.5 92.2 107.7 58.5 29.7 26.5 52.9 78.1 71.0 218.6 47.6 30.6 224.7 288.7 13.8 51.3 75.9 35.0 105.7 65.7 47.6 151.0 61.8 86.9 117.6 78.0 110.6 42.1 121.4 75.4 54.1 36.5 126.5 119.4 134.7 130.1 110.3 118.9 104.5 69.7 22.6 44.5 64.6 144.2 213.9 85.5 53.1 75.5 83.1 95.5 170.4 97.7 82.1 105.8 109.0 71.1 153.1 102.5 299.4 100.6 73.7 124.1 97.4 152.7 100.5 79.2 76.1 122.6 53.0 67.6 142.6 197.9 80.4 199.9 208.7 74.5 207.1 142.9 122.1 85.3 97.9 94.0 118.7 95.2 94.8 63.0 112.8 264.9 218.1 107.0 71.6 65.0 92.2 60.5 143.9 83.5 146.9 151.7 114.4 52.7 87.8 71.8 74.1 78.3 96.5 331.7 31.6 111.1 53.2 22.6 44.5 14.7 94.2 31.6 129.1 104.5 123.0 99.4 69.7 95.6 144.2 111.8 11.2 64.6 30.1 60.8 78.2 213.9 36.6 41.2 32.1 33.8 29.7 26.5 47.6 30.6 35.0 36.5 RPS5 S5 ENSG00000083845 "Ribosomal protein S5" P46782 19 58386400-58394806 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 495.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055878, HPA061979" Enhanced Supported "Endoplasmic reticulum,Cytosol" 860000 "Endoplasmic reticulum, Cytosol" "HPA055878: AB_2682954, HPA061979: AB_2684650" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-1)" "unprognostic (1.53e-1)" "unprognostic (2.37e-2)" "unprognostic (2.49e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (4.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.77e-1)" "unprognostic (1.81e-1)" "unprognostic (5.06e-1)" "prognostic unfavourable (4.75e-4)" "unprognostic (2.79e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (1.01e-1)" 93.2 62.4 40.6 71.7 36.4 118.0 111.7 28.4 34.9 105.3 100.7 34.6 69.1 51.1 108.4 66.2 159.0 103.7 81.4 50.9 33.3 28.9 63.1 160.1 79.1 162.1 37.8 30.9 199.2 376.8 19.4 45.0 72.5 31.9 112.3 50.9 45.5 145.6 54.9 162.7 122.7 63.3 81.1 39.0 103.1 66.0 66.8 34.0 136.8 134.5 144.1 129.6 104.5 131.0 150.0 86.6 16.9 44.9 64.8 138.0 156.5 75.0 110.5 42.2 67.1 82.3 106.6 66.1 42.0 69.9 51.8 33.1 82.3 55.5 156.3 53.0 59.5 49.0 67.0 103.5 21.5 42.4 495.1 61.8 61.5 103.8 102.1 103.6 52.7 135.2 172.2 53.7 122.8 67.5 78.5 83.7 55.2 61.0 100.1 71.2 70.0 149.3 97.3 60.5 137.0 57.2 95.0 63.4 79.1 29.4 84.6 86.3 48.8 125.9 42.5 78.3 57.5 31.2 91.4 112.5 190.6 115.2 49.0 77.6 42.9 16.9 44.9 8.6 54.2 41.1 99.7 150.0 94.6 70.4 82.9 141.7 138.0 106.0 6.5 64.8 30.1 86.6 74.7 156.5 40.6 36.4 28.4 34.9 33.3 28.9 37.8 30.9 31.9 34.0 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favourable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 90.0 65.3 64.1 110.2 70.2 166.3 152.8 37.0 50.4 125.4 149.9 38.8 57.4 73.0 91.6 97.7 166.8 87.7 81.5 70.0 51.5 44.4 88.5 91.3 104.0 243.5 66.0 36.2 206.6 441.2 26.1 64.0 67.9 64.7 152.5 83.9 53.3 109.1 72.1 129.5 139.9 96.3 157.8 84.5 137.8 87.5 67.2 53.2 127.9 147.0 119.7 125.8 207.4 143.4 237.2 135.7 30.1 75.5 129.7 274.9 399.9 106.2 69.9 71.1 83.2 120.6 186.1 85.4 71.9 93.8 86.4 72.3 58.1 49.3 244.4 71.2 68.6 52.3 79.6 110.6 93.9 127.3 76.2 161.1 90.5 105.3 147.3 85.3 80.5 154.3 202.4 57.5 169.7 103.8 67.6 99.8 93.2 64.0 180.6 573.5 133.3 47.6 141.4 71.9 116.2 119.6 91.5 71.1 95.6 27.2 115.8 148.5 75.4 311.8 76.1 49.8 53.3 51.5 112.3 47.2 91.4 165.9 33.7 128.3 29.0 30.1 75.5 23.3 111.6 67.1 193.2 237.2 205.0 150.5 135.7 196.8 274.9 215.8 12.8 129.7 60.6 126.1 152.7 399.9 64.1 70.2 37.0 50.4 51.5 44.4 66.0 36.2 64.7 53.2 RPS7 S7 ENSG00000171863 "Ribosomal protein S7" P62081 2 3575205-3580919 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056586 Approved Approved "Endoplasmic reticulum,Cytosol" 1000000 "Endoplasmic reticulum, Cytosol" "HPA056586: " "unprognostic (3.28e-3)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.00e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (5.27e-4)" "unprognostic (6.41e-2)" "unprognostic (6.02e-3)" "unprognostic (7.08e-2)" "unprognostic (5.60e-2)" "unprognostic (6.27e-2)" "prognostic unfavourable (1.34e-8)" "unprognostic (3.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" 54.0 42.1 41.7 57.4 47.8 91.9 112.1 35.1 52.6 57.9 54.4 22.5 35.3 38.3 49.4 70.5 75.2 60.6 80.9 42.7 35.6 28.9 88.1 184.7 40.5 73.8 35.4 49.9 128.7 94.3 19.0 42.3 56.0 46.5 49.6 61.0 27.5 61.1 46.8 96.7 74.9 53.8 46.2 35.2 74.2 55.7 120.7 30.3 59.0 49.0 129.1 89.6 54.8 62.3 124.7 91.6 22.4 53.7 83.8 117.9 145.9 62.2 61.0 94.0 100.9 93.5 205.2 154.4 75.6 132.1 125.9 73.5 105.4 98.5 208.4 126.5 87.4 68.7 106.2 122.8 111.3 65.2 143.3 76.1 44.8 151.5 225.7 131.6 79.2 172.2 185.4 78.0 169.7 147.0 117.3 105.9 127.3 83.9 145.8 293.8 138.7 94.7 116.5 95.9 185.3 142.2 76.6 107.2 161.3 40.0 154.2 230.1 84.8 191.0 68.6 75.8 49.9 52.1 121.1 119.0 216.7 204.2 79.7 158.7 84.4 22.4 53.7 19.9 74.4 47.3 109.5 124.7 107.1 94.6 91.6 107.1 117.9 103.2 11.4 83.8 44.3 87.8 90.6 145.9 41.7 47.8 35.1 52.6 35.6 28.9 35.4 49.9 46.5 30.3 RPS8 S8 ENSG00000142937 "Ribosomal protein S8" P62241 1 44775251-44778779 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029266 Enhanced "Endoplasmic reticulum,Cytosol" 52000 "Endoplasmic reticulum, Cytosol" "HPA029266: AB_10601611" "unprognostic (9.70e-3)" "unprognostic (2.26e-1)" "unprognostic (3.02e-1)" "unprognostic (9.75e-2)" "unprognostic (1.62e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.36e-5)" "unprognostic (1.02e-1)" "unprognostic (6.17e-2)" "unprognostic (7.30e-2)" "unprognostic (9.31e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (9.05e-9)" "unprognostic (1.94e-1)" "unprognostic (8.55e-2)" "unprognostic (8.83e-2)" "unprognostic (5.57e-2)" 55.7 60.7 44.8 44.4 46.3 100.1 82.0 50.1 65.5 69.6 47.8 33.8 37.0 40.7 61.9 48.4 78.0 66.7 43.9 36.8 34.6 23.7 41.6 74.1 36.5 77.7 34.8 34.6 195.0 98.3 13.1 37.2 45.4 36.8 53.5 42.5 32.3 61.0 72.7 53.7 91.2 45.6 39.4 35.6 57.0 47.4 71.9 29.0 64.8 40.9 97.3 72.0 52.7 71.2 146.1 98.0 15.3 50.2 61.2 128.4 168.5 100.6 50.4 81.1 106.7 141.0 221.9 132.7 74.1 117.5 104.8 84.4 86.5 110.3 191.0 81.7 89.7 69.1 103.9 129.0 77.6 69.1 181.5 71.2 71.8 114.9 200.4 141.4 69.8 176.5 214.1 69.8 187.5 125.1 105.7 134.3 97.4 79.7 155.4 151.4 177.1 87.3 125.3 99.3 213.1 117.5 86.6 86.8 100.2 40.0 224.7 293.7 78.5 284.6 85.3 52.1 91.4 79.9 125.8 106.0 103.9 144.4 63.7 169.9 62.4 10.3 50.2 15.3 55.1 49.1 94.1 146.1 101.4 76.7 79.2 124.5 128.4 106.7 5.0 61.2 38.1 98.0 84.2 168.5 44.8 46.3 50.1 65.5 34.6 23.7 34.8 34.6 36.8 29.0 RSAD2 "cig5, vig1, viperin" ENSG00000134321 "Radical S-adenosyl methionine domain containing 2" Q8WXG1 2 6865806-6898239 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 31.8" "Group enriched" "Detected in some" 5 "BJ hTERT+ SV40 Large T+: 30.4;BJ hTERT+ SV40 Large T+ RasG12V: 46.9;HMC-1: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 24.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA041160, HPA049409" Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA041160: AB_10795489, HPA049409: " "unprognostic (8.91e-2)" "unprognostic (3.85e-2)" "unprognostic (7.89e-2)" "prognostic unfavourable (4.60e-4)" "unprognostic (3.27e-1)" "unprognostic (3.25e-1)" "unprognostic (1.95e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (3.66e-3)" "unprognostic (9.47e-3)" "unprognostic (4.06e-2)" "unprognostic (1.27e-2)" "unprognostic (3.98e-2)" "unprognostic (4.54e-3)" "unprognostic (4.47e-2)" "unprognostic (1.79e-1)" 31.8 3.1 4.8 10.1 8.7 12.5 4.1 1.1 7.8 7.2 5.6 4.7 2.1 3.4 4.8 7.8 2.9 5.5 6.2 5.3 5.3 5.8 6.1 3.6 15.3 7.7 4.8 5.6 3.5 2.1 1.2 6.2 10.1 12.5 3.7 3.1 7.5 20.2 2.5 5.5 1.0 4.9 5.2 6.1 10.8 7.2 2.3 2.0 11.5 10.2 3.5 2.8 4.0 2.0 0.4 2.7 24.3 5.1 1.6 3.2 2.2 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.4 30.4 46.9 0.0 0.9 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 2.0 0.0 0.0 0.5 0.4 0.0 0.0 2.8 0.6 0.1 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 0.1 14.6 3.6 24.3 1.8 5.1 2.2 0.2 1.9 1.7 2.7 0.4 3.2 2.4 14.4 1.6 4.5 0.2 0.9 2.2 4.8 8.7 1.1 7.8 5.3 5.8 4.8 5.6 12.5 2.0 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Group enriched" "Detected in some" 4 "HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: , HPA044249: " "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favourable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 22.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 28.1 45.0 5.5 0.0 0.0 0.0 0.0 0.0 3.8 1.1 0.0 2.0 0.0 0.0 0.0 7.5 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 SARAF "MGC8721, TMEM66" ENSG00000133872 "Store-operated calcium entry associated regulatory factor" Q96BY9 8 30063012-30083208 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040400 Supported "Endoplasmic reticulum,Rods & Rings" 17000 "Endoplasmic reticulum" "Rods & Rings" "HPA040400: " "unprognostic (1.11e-1)" "unprognostic (4.78e-2)" "unprognostic (4.27e-3)" "unprognostic (1.38e-3)" "unprognostic (7.86e-3)" "unprognostic (1.91e-1)" "unprognostic (2.32e-1)" "prognostic favourable (5.28e-4)" "unprognostic (1.98e-1)" "unprognostic (1.74e-2)" "unprognostic (8.03e-2)" "unprognostic (6.70e-3)" "unprognostic (1.06e-2)" "unprognostic (5.09e-2)" "unprognostic (3.88e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-1)" 30.7 80.7 58.1 37.3 69.0 57.8 62.1 45.8 89.0 40.9 32.8 35.8 49.3 26.9 35.0 65.9 20.2 42.9 39.5 34.3 57.5 80.9 38.7 67.0 39.1 77.7 59.1 49.8 60.6 67.8 44.6 48.9 61.6 53.4 45.6 28.1 26.1 69.4 45.5 29.7 18.4 30.7 30.4 62.4 36.4 38.7 21.3 35.4 50.3 50.0 16.0 36.0 35.4 37.3 36.9 30.2 96.2 36.9 29.0 99.7 91.0 21.7 15.5 19.7 13.0 33.8 23.5 15.0 26.9 38.7 23.4 30.3 8.3 24.4 14.7 39.6 29.2 19.3 19.8 22.3 19.3 7.8 14.4 20.2 11.0 10.7 34.0 6.4 24.1 36.6 41.9 26.3 21.7 32.5 23.6 31.6 17.7 8.2 23.6 10.6 17.4 16.8 19.0 13.0 20.2 32.5 8.9 8.5 30.3 23.5 23.4 30.1 20.2 13.6 23.1 15.7 45.0 7.1 8.8 22.3 20.3 13.4 38.9 17.5 25.4 96.2 30.1 50.8 41.3 28.9 45.2 27.0 59.4 47.5 30.2 36.9 99.7 67.4 58.4 29.0 36.9 25.1 53.5 91.0 58.1 69.0 45.8 89.0 57.5 80.9 59.1 49.8 53.4 35.4 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favourable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favourable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 9.7 11.2 13.4 10.6 16.4 21.5 10.1 36.8 21.0 11.4 9.4 9.2 10.7 10.0 11.7 8.9 10.9 10.4 9.0 8.7 13.3 5.4 10.0 23.8 11.6 10.5 12.3 11.5 10.7 20.2 11.9 26.3 7.6 13.2 13.2 7.2 10.4 16.3 9.7 14.3 13.4 11.3 7.3 6.7 13.4 19.1 46.7 12.9 19.6 15.8 5.7 8.1 10.0 8.4 5.9 6.1 4.7 7.2 3.3 7.1 4.5 10.9 24.3 12.3 20.2 13.1 13.5 14.5 13.6 11.9 10.2 7.8 17.5 9.4 11.0 9.6 16.5 30.2 13.6 19.5 5.5 23.2 8.8 11.2 22.7 13.9 12.7 19.0 19.9 14.5 14.1 14.1 16.7 13.8 13.9 15.3 10.7 47.3 12.7 10.2 10.8 17.3 18.3 15.2 18.6 10.4 14.7 17.4 11.5 17.6 26.7 8.3 27.3 15.0 19.8 16.4 12.4 13.2 10.4 7.3 11.1 14.2 12.8 8.6 16.3 3.9 5.9 2.8 6.3 7.1 6.5 5.9 6.4 7.1 3.6 3.8 4.2 6.7 4.7 3.3 7.2 6.1 4.5 4.5 13.4 16.4 36.8 21.0 13.3 5.4 12.3 11.5 13.2 12.9 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: " "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 33.2 30.8 43.1 18.8 46.0 27.3 22.5 30.3 51.7 28.7 26.6 19.7 33.1 19.6 26.1 47.7 25.5 18.7 20.2 21.0 41.7 40.7 41.7 65.7 25.7 19.5 53.2 25.9 31.9 39.5 37.3 34.7 37.8 53.9 34.0 19.9 10.5 39.7 30.8 22.1 11.2 24.4 32.5 55.1 35.3 30.1 16.3 40.2 17.6 42.3 12.2 21.8 43.7 28.3 38.5 14.9 25.0 15.5 12.7 23.6 11.0 33.9 23.9 18.9 16.6 56.5 30.0 11.8 43.6 32.2 20.4 21.2 25.5 35.9 38.3 48.8 31.1 32.5 23.1 21.1 32.1 29.9 22.4 26.5 14.9 25.6 41.2 26.8 17.4 29.9 20.3 22.3 21.9 20.0 16.2 37.1 24.1 28.4 14.0 14.2 19.3 15.7 18.8 27.3 51.5 29.1 21.8 19.3 18.3 35.7 39.2 29.7 58.7 24.7 26.7 29.0 13.1 24.1 35.0 42.9 32.2 59.8 30.3 21.0 27.0 6.4 14.1 25.0 19.4 15.5 22.2 33.2 18.4 19.4 13.0 38.5 23.6 20.9 22.2 12.7 11.6 14.9 16.0 11.0 43.1 46.0 30.3 51.7 41.7 40.7 53.2 25.9 53.9 40.2 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved Supported "Endoplasmic reticulum,Vesicles" 4100000 Vesicles "Endoplasmic reticulum" "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favourable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favourable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.5 0.4 0.2 0.8 0.6 2.0 4.6 15.5 1.7 0.0 2.1 2.5 1.2 0.3 42.9 2.5 6.5 1.0 0.2 0.5 8.6 33.1 0.1 0.9 0.2 0.1 1.6 1.5 10.6 0.0 6.7 38.9 10.8 6.9 0.1 12.4 0.9 4.3 5.5 4.2 6.7 4.4 1.1 3.6 0.1 3.4 4.7 1.0 0.0 2.6 0.3 2.0 11.9 5.1 2.2 2.0 10.5 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 SERPINB7 MEGSIN ENSG00000166396 "Serpin family B member 7" O75635 18 63752935-63805376 "Disease related genes, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6" "Cell line enhanced" "Detected in some" "BJ: 45.7;fHDF/TERT166: 32.2;HaCaT: 78.8;HBEC3-KT: 25.0;HBF TERT88: 43.8;hTERT-HME1: 25.5;U-138 MG: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024200 Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Endoplasmic reticulum" Mitochondria "HPA024200: AB_1856730" "unprognostic (8.66e-3)" "unprognostic (6.31e-3)" "unprognostic (6.55e-2)" "unprognostic (4.03e-4)" "unprognostic (9.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (9.99e-2)" "unprognostic (4.70e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (2.02e-1)" "unprognostic (6.81e-2)" "unprognostic (1.62e-1)" "unprognostic (3.37e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-3)" 0.2 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 2.0 0.2 0.0 0.0 0.0 0.5 0.0 2.6 0.1 1.3 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.4 0.0 0.1 0.0 0.0 0.6 0.0 0.9 54.6 0.1 0.0 0.1 0.0 0.3 0.3 0.0 6.7 0.1 22.6 16.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.7 0.0 45.7 9.2 7.0 5.2 0.0 0.2 0.0 0.0 32.2 78.8 0.0 25.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.5 1.0 25.5 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 1.6 0.9 4.3 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 120.5" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853978 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Cell line enhanced" "Detected in many" "BEWO: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Supported "Endoplasmic reticulum,Centriolar satellite" 110000 "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: " "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favourable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favourable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavourable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 10.7 7.9 3.8 20.4 5.2 6.1 8.7 3.1 4.9 6.5 12.6 4.5 1.9 9.1 8.2 3.9 10.5 6.4 9.6 6.5 3.5 3.3 6.5 6.4 17.6 26.9 6.4 3.6 5.0 4.4 3.0 3.6 8.7 6.0 9.0 5.4 6.6 9.4 4.4 7.5 15.3 19.5 5.7 5.2 24.2 12.6 5.8 4.9 20.8 13.1 8.9 20.3 6.6 7.6 22.7 8.8 45.3 10.9 14.4 25.3 21.0 2.8 1.8 0.0 1.7 0.9 1.2 16.6 1.5 3.4 6.9 9.4 0.1 3.0 5.9 3.9 1.1 5.5 1.1 2.4 0.4 10.1 1.5 6.6 1.3 2.3 4.3 0.0 2.4 1.3 2.1 1.9 1.2 1.7 0.4 5.6 0.8 1.7 1.1 13.1 0.0 1.9 5.9 1.2 3.9 8.9 0.5 0.0 0.3 1.6 4.2 5.7 3.8 11.8 0.9 2.6 1.0 6.3 0.0 7.5 10.4 1.7 1.7 4.0 1.8 27.7 10.6 44.2 15.5 10.9 16.3 22.7 17.5 16.4 8.8 20.9 25.3 19.4 45.3 14.4 10.5 7.2 21.7 21.0 3.8 5.2 3.1 4.9 3.5 3.3 6.4 3.6 6.0 4.9 TAP2 "ABCB3, D6S217E, PSF2, RING11" ENSG00000204267 "Transporter 2, ATP binding cassette subfamily B member" Q03519 6 32821833-32838780 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.3;U-251 MG: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" 14000 "Endoplasmic reticulum" "Nuclear speckles" "HPA001312: AB_1080206" "unprognostic (2.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-2)" "prognostic unfavourable (1.51e-4)" "unprognostic (1.90e-1)" "prognostic unfavourable (5.22e-8)" "unprognostic (5.32e-1)" "unprognostic (4.17e-2)" "unprognostic (2.35e-1)" "unprognostic (4.71e-2)" 12.8 8.4 6.5 22.5 6.9 14.7 9.5 6.3 7.3 8.8 15.0 7.6 3.3 15.3 9.6 5.9 17.4 7.9 11.5 7.7 5.2 6.0 10.8 19.0 18.0 14.0 7.1 6.3 9.7 6.1 2.6 5.8 5.7 7.9 8.2 11.9 7.9 12.1 5.2 5.8 9.6 28.0 7.0 6.1 24.9 7.7 3.3 6.9 25.9 14.7 7.1 20.1 23.6 10.7 0.9 2.8 4.9 5.4 2.9 4.1 1.9 7.8 0.0 0.0 2.3 2.2 3.0 0.0 0.5 1.6 6.2 8.4 2.1 16.1 15.4 3.0 3.9 8.2 7.1 28.3 2.4 10.4 0.9 1.8 6.0 0.7 1.0 0.0 12.2 0.3 0.4 8.4 13.0 4.0 8.5 5.2 0.0 0.6 2.0 1.0 0.3 3.9 8.4 0.0 5.9 5.2 0.1 0.1 0.0 7.6 16.2 1.6 0.8 0.0 2.3 8.7 2.0 2.3 28.0 8.0 13.3 14.4 8.0 10.8 1.5 1.7 2.0 1.8 4.1 5.4 2.0 0.9 1.2 2.7 2.0 0.6 1.0 0.6 4.9 2.9 4.1 2.8 1.9 1.9 6.5 6.9 6.3 7.3 5.2 6.0 7.1 6.3 7.9 6.9 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell line enhanced" "Detected in many" "MCF7: 21.6;RPTEC TERT1: 24.9;T-47d: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: " "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favourable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.5 8.3 12.0 3.3 0.2 5.3 0.6 1.3 1.0 1.1 8.6 12.2 5.3 9.4 0.4 4.3 3.7 5.8 0.7 5.0 1.8 3.3 1.0 17.3 6.8 1.3 3.6 1.5 1.8 4.8 0.6 0.9 1.9 4.1 0.3 21.6 2.2 5.7 4.5 4.0 7.1 0.4 12.4 24.9 3.8 9.5 10.6 0.4 9.1 2.1 48.4 3.5 0.6 0.1 1.2 1.2 0.8 9.4 5.9 3.0 0.8 2.0 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 TMCC3 KIAA1145 ENSG00000057704 "Transmembrane and coiled-coil domain family 3" Q9ULS5 12 94567124-94650562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 17.9;Karpas-707: 24.2;U-266/84: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.2;neutrophil: 30.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014272 Approved Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA014272: AB_1858059" "unprognostic (1.03e-1)" "unprognostic (2.54e-1)" "unprognostic (1.52e-3)" "prognostic unfavourable (4.87e-4)" "unprognostic (1.30e-1)" "unprognostic (8.63e-2)" "unprognostic (5.87e-2)" "unprognostic (1.17e-2)" "unprognostic (9.12e-2)" "unprognostic (3.45e-3)" "unprognostic (1.24e-1)" "unprognostic (7.73e-2)" "unprognostic (1.80e-3)" "unprognostic (9.11e-2)" "unprognostic (2.32e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" 10.6 4.0 10.2 7.7 20.9 8.1 9.9 2.7 9.9 11.0 19.7 32.6 6.8 13.1 6.9 3.0 6.1 5.5 4.7 4.4 14.7 10.8 7.4 3.5 5.9 3.9 25.8 7.4 5.2 2.8 5.0 4.7 15.7 17.8 7.7 15.0 7.3 5.8 5.1 20.2 7.0 23.0 7.2 25.5 11.6 6.4 2.2 20.4 0.1 12.0 3.3 5.3 7.2 5.9 2.5 1.1 30.0 3.0 1.3 1.5 1.1 4.3 0.2 1.1 0.0 0.4 1.6 7.9 0.0 0.0 0.2 1.1 0.0 0.9 0.1 0.0 0.0 10.8 6.1 7.3 1.5 1.9 1.5 2.8 0.4 0.0 0.3 0.0 5.9 1.0 1.0 4.1 5.9 17.9 0.1 24.2 0.6 0.2 0.0 0.2 0.5 3.7 0.0 0.3 2.8 1.2 9.2 0.1 0.5 0.1 4.6 0.2 0.0 0.2 10.7 0.0 0.1 0.0 1.9 11.2 16.1 0.1 2.2 0.9 1.0 6.5 1.8 19.2 1.5 2.6 0.1 2.5 0.6 0.8 1.0 1.4 0.0 1.0 30.0 1.3 3.0 1.1 0.0 1.1 10.2 20.9 2.7 9.9 14.7 10.8 25.8 7.4 17.8 20.4 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671109-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA072536: " "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 8.7 24.4 26.7 6.2 32.0 4.3 12.9 25.7 40.0 13.9 12.5 13.5 5.8 18.9 14.3 19.3 18.0 16.3 12.6 8.1 25.5 40.7 25.8 52.7 9.0 8.8 28.3 22.6 21.0 23.8 9.2 12.9 7.9 31.7 19.0 13.3 25.7 9.6 11.7 2.0 6.8 17.4 13.4 29.1 6.5 20.3 8.4 10.7 5.8 14.6 11.1 11.6 14.1 11.6 22.3 14.3 6.4 0.2 4.0 25.7 11.9 68.3 10.4 7.7 21.8 21.2 16.3 6.5 13.8 19.0 12.8 19.9 15.8 17.7 8.4 15.5 17.4 26.2 17.1 23.2 21.6 33.8 14.0 12.4 17.0 25.9 6.9 6.3 15.5 14.6 16.3 14.0 3.1 17.3 2.6 24.0 15.2 13.9 12.3 7.2 4.5 18.1 9.7 11.0 6.6 24.8 13.2 40.2 19.5 15.4 12.4 25.7 19.1 12.2 12.6 17.8 23.9 6.9 22.2 11.6 9.8 12.6 25.0 4.0 14.1 6.4 0.2 6.4 16.4 0.0 10.6 22.3 21.2 17.2 7.8 13.2 16.4 17.5 0.9 4.0 0.0 14.3 25.7 11.9 26.7 32.0 25.7 40.0 25.5 40.7 28.3 22.6 31.7 10.7 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: " "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.0 2.5 2.8 3.0 0.8 0.4 5.4 2.9 0.9 1.1 1.2 2.0 3.2 5.3 3.6 1.4 2.8 1.7 1.3 2.5 7.0 2.7 6.3 6.4 2.6 0.5 3.6 5.3 1.1 1.5 1.4 1.1 1.3 4.4 8.5 0.9 2.6 3.2 4.0 4.8 2.6 2.7 4.4 4.4 1.1 3.1 3.3 3.2 4.0 3.0 2.2 3.6 3.3 6.5 4.5 4.9 7.1 3.1 5.0 4.0 3.5 2.3 3.3 2.3 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: " "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favourable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 35.9 23.2 16.1 18.3 19.9 19.3 28.5 30.6 26.7 25.3 27.4 21.3 20.3 24.9 30.2 23.1 41.2 16.2 30.1 11.2 31.9 27.4 14.6 28.7 23.4 35.3 28.0 37.2 25.8 30.8 20.3 25.5 22.0 24.6 50.5 16.8 15.7 30.7 25.8 23.9 19.1 35.1 12.3 31.5 20.0 33.9 22.4 23.4 19.4 24.6 20.9 24.2 36.5 25.5 25.3 14.6 35.4 31.8 71.7 26.9 27.7 29.9 23.1 25.1 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 118.9" "Cell line enhanced" "Detected in many" "ASC diff: 92.2;ASC TERT1: 27.0;HSkMC: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3;myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" Vesicles "HPA062101: " "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 5.3 5.2 1.6 3.0 7.3 0.6 12.5 0.3 1.9 8.6 2.7 1.9 2.5 1.0 8.5 5.7 4.4 5.2 5.7 5.7 1.3 0.9 1.4 45.2 5.8 5.2 4.4 0.7 6.4 20.2 0.3 25.1 20.2 2.1 5.9 1.8 3.1 23.9 2.2 2.4 118.9 1.7 6.6 2.2 2.2 2.0 5.4 4.4 0.0 6.5 3.7 12.2 7.7 18.5 0.5 2.9 0.9 3.3 0.0 0.5 2.0 6.0 0.4 0.5 2.1 92.2 27.0 0.0 14.5 13.5 2.0 19.0 0.5 0.1 0.0 7.2 9.5 6.9 0.5 2.8 5.2 1.5 1.8 5.0 2.2 1.7 5.8 0.0 0.3 28.4 1.6 3.7 5.6 0.7 0.1 0.7 4.9 0.0 0.0 0.1 0.7 3.6 0.0 5.1 0.0 0.1 0.2 0.6 4.3 3.5 1.8 1.5 0.1 2.8 2.0 14.1 9.9 0.1 3.2 11.9 6.8 0.0 11.1 0.4 9.3 0.0 3.3 0.9 0.3 0.0 0.0 0.5 0.2 0.3 2.9 0.0 0.1 0.5 0.4 0.0 0.5 1.6 0.0 2.0 1.6 7.3 0.3 1.9 1.3 0.9 4.4 0.7 2.1 4.4 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257546 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" 740000 "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 21.8 24.2 13.6 18.5 18.3 15.5 19.7 14.1 12.3 14.4 20.7 17.2 27.0 17.7 17.5 19.2 25.0 13.3 15.0 11.3 13.5 11.9 24.9 29.2 20.0 25.3 22.6 9.2 15.5 23.9 18.4 19.0 21.9 16.3 14.2 21.2 13.3 21.0 27.9 12.5 16.7 23.4 17.0 24.9 29.1 18.1 12.9 17.9 37.5 23.5 17.6 17.4 20.2 19.9 9.4 17.0 9.6 17.5 12.6 12.5 13.3 13.6 12.6 17.5 9.4 14.0 11.0 18.8 17.2 13.9 17.4 22.3 12.7 25.2 19.5 16.2 11.5 13.5 30.9 11.3 31.7 19.6 10.6 14.2 11.0 12.5 12.2 32.6 14.4 13.1 10.4 11.7 8.6 15.4 11.7 13.5 16.5 16.8 14.5 17.6 19.9 15.8 15.4 31.6 11.7 16.8 17.8 11.1 8.2 13.7 9.2 12.3 13.5 14.6 9.9 18.4 17.1 13.0 15.6 11.8 11.9 16.0 8.1 18.6 17.2 9.6 15.4 7.2 10.2 17.5 12.5 9.4 10.9 10.5 16.2 7.4 10.8 12.0 5.7 12.6 12.6 17.0 12.1 13.3 13.6 18.3 14.1 12.3 13.5 11.9 22.6 9.2 16.3 17.9 TP53I11 PIG11 ENSG00000175274 "Tumor protein p53 inducible protein 11" O14683 11 44885903-44951306 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 83.1;T-47d: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 23.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059727, HPA061276" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "HPA059727: , HPA061276: " "prognostic unfavourable (7.33e-5)" "unprognostic (1.87e-1)" "unprognostic (4.03e-2)" "unprognostic (3.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "prognostic unfavourable (6.12e-4)" "unprognostic (6.55e-2)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (4.65e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" 33.3 8.0 20.0 13.3 10.7 19.0 27.6 36.0 26.2 14.7 21.1 8.6 17.6 13.6 16.8 10.4 15.6 21.5 28.5 33.1 8.4 12.3 12.5 7.8 21.4 12.8 5.8 8.6 18.2 18.5 3.0 9.5 16.6 14.1 20.6 19.4 17.6 18.9 11.9 12.6 14.5 21.1 23.5 7.4 28.2 18.4 9.9 5.5 6.7 18.9 12.7 14.9 15.1 19.1 5.2 14.1 23.7 11.1 4.6 4.4 2.1 0.0 17.3 5.9 8.4 6.3 0.4 0.1 5.6 10.9 1.9 2.5 1.0 0.1 3.0 4.8 1.5 3.3 3.4 0.1 0.7 6.4 3.4 0.2 0.1 0.0 11.7 0.1 23.4 27.1 0.4 2.7 1.2 6.5 0.4 0.0 2.4 14.8 0.3 27.2 10.8 5.8 13.2 3.6 1.4 0.0 1.0 83.1 3.0 9.7 21.1 0.0 46.8 1.6 1.5 13.0 9.2 19.9 0.0 0.1 0.0 0.0 0.0 1.7 3.6 0.0 3.1 0.0 3.1 3.2 4.4 4.9 0.6 3.2 2.6 5.2 0.0 1.1 23.7 4.6 11.1 14.1 0.5 2.1 20.0 10.7 36.0 26.2 8.4 12.3 5.8 8.6 14.1 5.5 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Cell line enhanced" "Detected in some" "BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA049690: , HPA068342: " "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 7.1 0.0 5.2 0.0 0.0 1.2 5.3 0.0 0.0 9.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.7 2.4 0.0 8.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Group enriched" "Detected in some" 4 "HDLM-2: 9.9;Karpas-707: 2.9" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA068342 Approved "Endoplasmic reticulum,Cytosol" Cytosol "Endoplasmic reticulum" "HPA068342: " "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 9.9 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225889 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.9;skeletal muscle: 101.1" "Cell line enhanced" "Detected in all" "RT4: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: " "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favourable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 11.3 5.9 14.7 8.3 15.7 7.6 8.6 20.5 20.1 7.1 23.5 15.4 4.2 15.5 6.1 8.0 14.9 9.6 21.9 71.9 15.1 12.4 9.5 7.7 11.0 9.8 14.3 15.6 4.1 6.5 16.8 11.0 9.7 16.2 7.8 11.9 23.8 22.9 7.7 101.1 21.6 23.7 7.9 11.7 12.2 26.9 7.0 10.6 4.9 14.4 31.9 14.2 19.1 10.5 7.1 4.8 1.6 4.3 1.7 1.8 1.1 7.4 6.5 12.9 5.6 9.0 8.9 17.0 10.1 11.4 6.6 7.2 4.3 10.6 14.6 5.3 24.9 3.6 8.9 23.1 7.2 13.2 6.4 10.0 6.6 11.9 4.5 11.4 8.0 7.5 10.0 14.5 13.4 13.2 5.1 11.7 8.3 3.1 1.2 6.0 5.6 5.0 5.3 4.8 12.2 9.1 56.2 8.3 9.8 3.8 5.6 5.4 5.0 9.7 13.5 5.7 6.8 34.3 5.8 8.7 7.4 13.2 6.3 10.0 5.5 1.6 2.5 1.0 1.2 4.3 1.1 5.0 1.8 1.5 2.8 7.1 0.8 1.8 1.1 1.7 2.4 4.8 0.8 1.1 14.7 15.7 20.5 20.1 15.1 12.4 14.3 15.6 16.2 10.6 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.1;thyroid gland: 15.5" "Cell line enhanced" "Detected in some" "HHSteC: 9.9;HSkMC: 6.6;U-266/70: 13.1;U-266/84: 6.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: " "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.4 5.4 1.8 3.0 2.5 3.3 1.6 1.3 2.1 2.6 1.4 1.1 7.2 2.2 2.8 1.9 0.8 3.5 3.1 5.9 2.4 3.0 1.0 1.1 2.1 2.9 2.7 1.3 5.8 0.9 1.5 6.8 1.8 3.8 2.1 1.1 2.9 0.9 1.9 1.2 1.1 1.7 2.1 4.2 4.7 1.5 16.1 1.6 2.7 15.5 0.7 2.8 3.0 5.2 5.5 5.1 3.6 1.3 7.8 4.1 1.5 0.2 0.4 1.0 0.8 0.6 0.6 0.6 2.4 0.8 0.0 0.0 0.3 0.3 0.7 0.2 3.6 0.3 0.6 0.6 0.4 0.4 0.5 0.2 0.5 0.7 9.9 0.5 0.6 6.6 0.5 2.1 0.2 0.2 0.5 1.5 0.3 0.4 0.3 0.8 3.8 0.0 0.5 0.2 1.0 0.3 0.9 0.8 0.5 0.1 0.3 0.4 0.3 0.3 0.7 1.2 0.4 0.1 0.2 13.1 6.6 0.4 0.3 0.2 0.4 3.6 1.3 0.1 3.3 1.1 3.4 3.6 1.6 3.3 1.5 5.5 4.1 4.0 0.5 7.8 0.8 5.1 0.4 1.5 1.8 2.5 1.3 2.1 2.4 3.0 2.7 1.3 3.8 1.6 TSN "BCLF-1, REHF-1, TRSLN" ENSG00000211460 Translin Q15631 2 121737103-121767853 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059561 Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" 320000 "Nucleoplasm, Endoplasmic reticulum" "HPA059561: " "unprognostic (3.15e-2)" "unprognostic (1.83e-1)" "unprognostic (3.53e-1)" "prognostic unfavourable (7.05e-4)" "unprognostic (7.13e-3)" "unprognostic (3.12e-2)" "prognostic unfavourable (3.06e-4)" "unprognostic (2.32e-2)" "unprognostic (7.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.10e-1)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (6.48e-2)" "unprognostic (1.04e-2)" "unprognostic (3.42e-2)" "unprognostic (3.18e-1)" 14.9 18.7 23.1 13.0 24.6 43.0 25.6 17.8 27.7 18.6 23.1 23.7 11.8 17.2 17.9 19.1 18.2 15.2 16.3 18.7 20.6 23.0 24.7 22.0 15.0 22.6 22.8 20.1 17.5 20.7 19.3 17.9 13.8 23.3 15.0 18.9 16.5 16.3 18.2 29.4 18.9 16.4 14.3 22.0 17.5 15.4 33.9 17.6 28.3 17.2 18.7 17.4 13.9 14.2 22.1 22.7 22.0 24.4 19.6 23.1 20.7 21.4 9.7 14.4 12.1 13.3 10.6 8.0 18.4 16.7 19.3 19.1 27.1 11.8 29.9 21.7 16.5 10.0 21.0 16.9 26.8 16.6 17.2 17.6 14.0 24.2 14.9 24.6 12.6 9.0 18.7 21.9 14.5 15.8 26.6 14.3 17.4 11.0 14.9 27.6 17.5 18.5 25.2 16.1 22.0 23.3 14.2 18.9 11.8 12.0 17.3 20.6 11.5 18.4 11.8 13.9 23.7 9.2 17.3 13.3 37.7 33.5 16.1 16.7 16.8 17.2 24.4 22.0 19.6 22.2 22.7 22.1 20.4 17.0 22.7 18.0 23.1 20.1 7.9 19.6 19.0 16.5 20.2 20.7 23.1 24.6 17.8 27.7 20.6 23.0 22.8 20.1 23.3 17.6 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15, small subunit processome component" Q8TED0 5 73565443-73583377 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Supported "Nucleoli,Endoplasmic reticulum" "Nucleoli, Endoplasmic reticulum" "HPA044697: " "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 17.1 11.8 6.5 9.4 11.7 38.6 13.2 8.7 12.5 7.5 8.6 10.4 9.3 7.0 11.3 8.7 13.6 10.4 6.7 8.8 12.9 5.6 9.3 12.9 10.2 12.1 11.0 8.0 11.0 9.7 11.8 16.4 8.8 12.5 10.1 10.9 7.5 10.9 6.6 14.5 18.3 10.7 9.9 10.3 11.4 11.9 10.1 10.0 11.4 10.3 13.2 12.8 9.5 9.4 8.3 9.0 4.6 8.0 8.8 10.8 5.4 10.7 11.7 7.9 23.9 6.9 8.2 15.0 12.8 7.5 14.6 16.2 13.0 14.4 24.3 13.0 8.7 9.1 13.5 23.9 22.6 11.9 9.8 11.2 12.4 10.6 8.5 10.1 9.2 8.3 10.8 16.5 18.5 10.0 17.0 13.4 12.3 13.6 15.4 7.2 10.7 6.7 12.3 12.2 23.5 8.7 14.7 8.2 8.8 11.6 9.5 13.5 12.2 7.5 8.1 8.7 12.0 10.1 25.0 9.9 13.1 31.4 13.7 17.5 12.6 2.5 7.0 4.6 9.7 8.0 9.7 8.3 9.8 10.6 9.0 7.2 10.5 10.8 3.8 8.8 7.3 6.5 7.9 5.4 6.5 11.7 8.7 12.5 12.9 5.6 11.0 8.0 12.5 10.0 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: " "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavourable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.4 41.2 13.4 20.7 28.7 17.7 21.6 32.6 23.3 20.4 27.4 27.0 29.5 11.8 48.8 22.0 25.5 15.5 18.7 25.4 30.2 19.5 15.1 23.6 28.4 28.0 17.1 18.6 27.0 16.0 26.2 22.3 21.6 19.8 20.9 21.0 56.4 15.9 9.0 15.1 21.3 8.8 23.5 24.3 25.2 23.9 9.6 21.9 18.6 15.8 21.6 32.8 14.7 30.4 27.4 26.2 21.7 26.9 32.4 37.2 16.4 30.2 10.5 27.6 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 VTN VN ENSG00000109072 Vitronectin P04004 17 28367276-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "liver: 321.7" "Cell line enriched" "Detected in some" 11 "CACO-2: 164.9" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016695, CAB016765, HPA060933" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" 224300000000 32000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favourable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.2 0.0 0.0 0.0 321.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.7 2.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 164.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 15.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.9 0.0 0.9 0.9 0.1 0.3 0.6 2.1 0.6 0.7 0.0 0.2 0.0 0.1 WLS "C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls" ENSG00000116729 "Wntless Wnt ligand secretion mediator" Q5T9L3 1 68098473-68233120 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 71.8;ASC TERT1: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 10.0;neutrophil: 29.1" "Group enriched" "Detected in many" 46 "granulocytes: 29.1;monocytes: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069520 Approved Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "HPA069520: " "prognostic favourable (4.03e-4)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (8.13e-3)" "unprognostic (5.93e-2)" "unprognostic (4.51e-3)" "unprognostic (5.41e-3)" "unprognostic (7.46e-3)" "unprognostic (7.70e-2)" "prognostic favourable (9.43e-4)" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "prognostic favourable (3.67e-7)" "unprognostic (4.48e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (3.51e-4)" 13.7 17.2 33.5 14.3 39.0 1.5 14.5 6.8 26.6 20.0 28.3 25.8 51.6 9.1 19.5 55.1 26.7 19.9 37.1 24.1 23.1 25.4 36.8 8.9 20.3 6.9 27.0 18.6 31.4 34.7 12.1 9.8 29.2 44.5 29.0 22.8 37.8 14.5 47.4 5.3 19.3 14.1 46.2 30.5 10.8 24.4 12.2 22.3 1.9 8.9 13.5 8.2 29.6 17.0 0.0 0.4 29.1 10.0 0.0 0.0 1.9 2.0 3.0 71.8 0.0 39.8 55.6 41.6 9.9 24.5 13.9 19.3 4.3 4.7 0.0 10.0 2.8 20.8 16.1 16.3 11.8 0.1 12.0 0.0 8.6 0.0 34.8 0.0 0.1 39.7 11.0 34.0 11.2 32.5 0.0 0.1 20.4 0.3 0.0 0.2 3.2 4.8 0.0 15.1 0.0 2.4 10.7 4.0 8.4 9.1 0.4 11.9 1.9 0.3 37.7 13.3 10.7 21.3 13.4 4.8 0.1 0.0 30.7 0.3 24.3 0.0 10.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.1 0.0 0.3 0.1 0.0 1.9 33.5 39.0 6.8 23.8 23.1 25.4 27.0 18.6 44.5 22.3 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Cell line enhanced" "Detected in many" "ASC diff: 18.8;U-2197: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.6 0.0 18.8 11.7 3.2 8.4 4.3 0.9 0.4 0.1 0.2 2.0 0.0 10.1 0.2 0.0 1.7 1.5 4.0 0.2 2.5 0.0 0.0 0.2 3.6 3.4 4.3 0.2 5.4 0.8 0.0 0.3 7.9 0.9 0.3 0.0 3.9 2.8 0.0 1.2 0.0 0.4 0.0 3.8 0.7 5.1 0.6 2.6 0.5 0.6 2.3 0.0 8.8 1.0 19.3 0.0 8.8 0.5 3.8 9.8 4.1 7.4 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 ZMYM2 "FIM, MYM, RAMP, ZNF198" ENSG00000121741 "Zinc finger MYM-type containing 2" Q9UBW7 13 19958670-20091829 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031765 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA031765: AB_10601927" "unprognostic (2.96e-1)" "unprognostic (3.42e-3)" "unprognostic (1.85e-1)" "unprognostic (1.69e-1)" "unprognostic (7.71e-2)" "unprognostic (2.33e-1)" "unprognostic (2.66e-3)" "unprognostic (1.16e-1)" "unprognostic (6.78e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (2.80e-2)" "unprognostic (6.65e-3)" "unprognostic (2.05e-1)" "unprognostic (8.74e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.07e-4)" 15.0 17.3 15.9 18.1 23.3 22.2 16.1 23.9 26.8 18.3 16.8 14.0 13.7 13.3 20.0 14.0 18.5 16.1 15.7 17.1 14.4 12.0 17.3 13.7 15.4 14.2 12.9 20.2 21.7 16.2 17.1 32.1 14.0 23.2 19.4 13.8 13.8 18.2 17.6 19.7 18.3 14.5 15.3 16.2 16.3 16.0 44.5 16.5 38.0 24.3 10.4 19.7 19.5 17.2 5.5 6.3 7.4 5.9 5.4 7.9 3.5 6.3 5.7 22.0 9.5 9.7 10.5 10.5 6.6 10.6 8.6 10.3 8.8 13.1 15.2 6.1 9.3 10.2 16.2 7.1 11.7 6.1 4.6 26.9 8.6 4.4 9.8 22.7 8.2 10.3 13.3 6.8 7.1 14.6 10.2 10.8 11.8 9.0 21.9 6.4 20.4 3.6 24.5 24.0 7.1 6.7 9.3 25.8 25.7 12.8 9.2 12.0 12.2 16.2 8.5 4.3 6.8 5.2 3.5 8.6 6.7 15.7 3.6 5.3 10.2 0.2 5.2 4.0 5.5 5.9 6.7 5.5 7.5 5.6 6.1 4.5 7.9 6.9 7.4 5.4 4.9 6.3 5.4 3.5 15.9 23.3 23.9 26.8 14.4 12.0 12.9 20.2 23.2 16.5 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773811 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favourable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavourable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 11.8 11.4 9.0 10.4 13.5 10.7 15.2 19.8 15.2 12.5 11.4 11.2 8.6 7.8 14.0 10.5 17.2 8.9 8.0 10.3 9.9 7.6 12.2 19.6 9.6 11.7 10.3 9.9 11.9 16.8 14.9 14.4 10.4 17.0 11.4 14.3 7.9 15.2 11.0 24.1 22.9 10.7 12.2 12.5 11.7 12.0 25.0 10.9 18.6 9.4 12.4 15.8 11.8 13.1 8.3 12.3 8.6 13.2 7.3 11.8 7.2 12.0 7.7 15.8 11.1 10.3 10.7 9.2 13.6 11.5 17.2 17.5 19.9 22.3 15.1 17.9 13.6 16.9 19.9 17.0 24.6 10.4 8.2 16.0 6.8 12.2 10.9 15.5 9.8 9.1 11.1 18.3 14.9 17.7 18.3 5.6 18.0 6.2 14.9 10.7 10.0 15.3 14.0 16.5 17.0 11.4 11.6 6.3 7.5 15.4 12.8 5.7 23.6 9.1 9.9 14.4 23.1 7.9 15.0 3.3 5.5 16.0 4.7 20.0 16.7 7.4 9.5 8.6 8.8 13.2 11.8 8.3 8.3 7.6 12.3 7.2 7.9 9.4 2.7 7.3 11.1 3.6 7.3 7.2 9.0 13.5 19.8 15.2 9.9 7.6 10.3 9.9 17.0 10.9